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ABSTRACT 
 Perineuronal nets (PNNs) are specialized extracellular matrix structures that surround 
subsets of neurons in the central nervous system (CNS). They help in maintaining a stable 
excitatory-inhibitory balance in the brain, and the adult loss of PNNs can lead to a period of 
increased synaptic plasticity. Furthermore, the loss of PNNs can affect cortical networks and 
influence learning, memory, and cognition. The aim of this thesis was to test the effect that 
degrading PNNs in the medial prefrontal (mPFC) and posterior parietal (PPC) cortices had on 
spatial working memory (WM). To do this, the spatial WM of Long-Evans rats was measured 
using the trial unique, delayed nonmatching-to-location (TUNL) task in touchscreen-equipped 
operant conditioning chambers. Rats were trained in this task and then assigned to either a 
penicillinase (PEN) control or chondroitinase ABC (ChABC) treatment. ChABC is an enzyme 
that compromises the structure of PNNs by degrading one of their major components: 
chondroitin sulfate proteoglycans (CSPGs). Surgeries were performed to infuse these enzymes 
into the medial prefrontal cortex (mPFC) in a first set of rats and into the posterior parietal 
cortex (PPC) in a second set of rats. All rats were trained under a standard 6 s delay and then 
tested under 4 conditions: a 6 s delay, a variable 2 s or 6 s delay, a 2 s delay with a 1s inter-trial 
interval (interference condition), and a 20 s delay. Rats that received mPFC ChABC infusions 
initially performed better than controls in the 20 s delay condition, but did not perform any 
differently in any of the other three conditions. Rats that received PPC ChABC infusions did not 
perform significantly differently from controls in any condition. Immunohistochemical analysis 
confirmed that CSPGs were degraded in both cortical regions. This suggests that PNNs in the 
mPFC are involved in learning a novel delay in a spatial WM task, but that they are not essential 
for general spatial WM function. Furthermore, it appears that PNNs in the PPC are not involved 
in spatial WM. Ultimately, these findings contribute to a growing body of literature that explores 
how cortical PNNs are involved in cognition.  
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1.0 INTRODUCTION 
1.1 Spatial Cognition and Spatial Working Memory 
 Spatial cognition refers to the acquisition, organization, revision, and application of 
knowledge regarding one’s spatial surroundings (Burgess 2008). Central to spatial cognition is 
spatial working memory (WM), which is the ability to temporarily store and reorganize visual 
information (Awh and Jonides 2001). Two processing systems are thought to underlie spatial 
WM: allocentric and egocentric processing (Burgess 2006). These processing systems are crucial 
for an organism to gather visual information from their environment and effectively navigate in 
their surroundings. Allocentric navigation relies on outside cues, and tracks the location of 
objects with respect to other objects (Burgess 2006). Egocentric navigation relies on internal 
cues, and tracks objects relative to one’s own body (Burgess 2006). In humans, imaging 
techniques such as functional magnetic resonance imaging (fMRI) and positron emission 
tomography have been paired with computer-based tasks to test what brain regions are involved 
in spatial WM (Jonides et al. 1993; D’Esposito et al. 1998). This imaging technology has helped 
us to better understand the cortical network that underlies spatial WM. Additionally, new 
imaging technology has important implications with regards to studying CNS disorders, since 
patients with autism, schizophrenia, and epilepsy commonly have deficits in spatial WM (Rahko 
et al. 2016; Starc et al. 2017; Reyes et al. 2018). In rats, several tasks have been developed that 
test spatial WM, including the Morris Water maze, T maze, Y maze, radial arm maze, and 
delayed non-matching to sample tasks (Dudchenko 2004). From research in humans, primates, 
and rats, it has been made clear that the prefrontal cortex (PFC), hippocampus, and posterior 
parietal cortex (PPC) play important roles in spatial WM (Eriksson et al. 2015). Further research 
is required to understand exactly how neurons communicate between the PFC, hippocampus, and 
PPC, as well as other brain areas, in maintaining functional spatial cognition. 
 
1.2 Medial Prefrontal Cortex 
 In humans, the frontal lobe is at the front of the brain and is classified as one of the 
brain’s four cortical lobes, with the others being the parietal, temporal, and occipital lobes. The 
prefrontal cortex (PFC) is found in the most anterior part of the frontal lobe and can be 
subdivided into caudal, lateral (dorsolateral and ventrolateral), medial, and orbitofrontal regions 
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(Murray et al. 2016). As its name suggests, the medial prefrontal cortex (mPFC) exists medially 
within the PFC. 
 Functionally, the rat PFC appears to combine features of the human orbitofrontal and 
dorsolateral prefrontal cortices (Uylings et al. 2003). It is interconnected with many other brain 
regions, including cortical, subcortical, and brain stem sites (Alvarez and Emory 2006). For 
example, bidirectional projections between the mPFC and amygdala modulate anxiety-related 
and social behaviors (Felix-Ortiz et al. 2016). Additionally, many types of memory rely on 
communication between the mPFC and the hippocampus (Wirt & Hyman 2017), and executive 
control relies on fronto-parietal circuits (Eriksson et al. 2015). Furthermore, the mPFC is also 
involved in decision-making (Walton et al. 2002), impulsivity (Narayanan et al. 2006), attention 
(Kim et al. 2016b), the maintenance of emotional responses (Smith et al. 2018), and learning 
(Rushworth et al. 2011). For the purposes of this thesis, however, the remainder of this section 
will focus on the role that the mPFC plays in learning and memory. 
 One way that the mPFC contributes to learning and memory is through the regulation of 
motivation. Motivation largely influences attention and the capacity for an organism to learn 
(Lang 1995). Studies in humans and rats have shown that the ventral mPFC is tied to the 
motivation related to the anticipation of an outcome (Rushworth et al. 2011). This is consistent 
with the fact that the ventral mPFC communicates with the hypothalamus, which has been 
strongly implicated with emotion and motivation (Reppucci and Petrovich 2016). In rats, the 
mPFC mediates motivation in the context of a food reward (Petrovich et al. 2007), but also other 
forms of motivation such as voluntary wheel running (Basso and Morrell 2015). The mPFC is 
also involved in memory consolidation. Inactivation of the mPFC either several weeks before or 
soon after the introduction of a memory task leads to memory impairment (Tuscher et al. 2018; 
Leon et al. 2010). If the mPFC is inactivated long after the introduction of a memory task, 
memory is not impaired (Carballo-Màrquez et al. 2007). Therefore, the role of the mPFC in 
memory consolidation is timing-specific.  
 The mPFC is also involved in spatial WM. The role of the mPFC in spatial WM appears 
to be quite specific, as was found by a group that tested the spatial WM of mPFC-lesioned rats 
using visuospatial conditional discrimination in a Y maze (Delatour and Gisquet-Verrier 1999). 
They found that when trained on a 5 s delay, mPFC lesions impaired the performance of rats 
when they were switched to a novel 20 s delay. Interestingly, mPFC-lesioned rats that were 
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trained using a variable 0, 5, 10, or 20 s delay were not impaired when switched to a non-
variable 20 s delay (Gisquet-Verrier et al. 2000). This implies that the mPFC is involved in 
adapting to a novel WM delays. To conclude, the mPFC is an integral brain region in humans, 
monkeys, and rodents. Notably, it plays a key role in many forms of WM, including spatial WM. 
 
1.3 Posterior Parietal Cortex 
 The posterior parietal cortex (PPC) is part of the parietal lobe, and is located posterior to 
the primary somatosensory cortex. It forms connections to areas throughout the brain, including 
the medial prefrontal cortex, orbitofrontal cortex, somatosensory cortex, striatum, thalamus, and 
visual areas (Whitlock 2017). The PPC is involved in visual decision-making, planned 
movement, spatial attention, spatial navigation, and spatial WM (Licata et al. 2017; Whitlock 
2017). This has been demonstrated repeatedly in primate research, with fewer rodent studies 
tying the PPC to these cognitive functions. Damage to the PPC, particularly in the right 
hemisphere, can result in hemispatial neglect, which refers to the inability to orient or respond to 
a meaningful stimulus presented to one side of the body or visual field (King and Corwin 1993). 
This phenomenon has been observed in rodents, monkeys, and humans (King and Corwin 1993). 
Notably, abnormalities in PPC function have also been tied to the cognitive deficits in certain 
CNS disorders. For example, neuroimaging studies found that patients with Alzheimer’s disease 
showed hypometabolism and hypoperfusion in the PPC (Foster et al. 1984; Jacobs et al. 2012). 
Additionally, an fMRI study recently found that dysfunction of the PPC in human schizophrenia 
patients is associated with decreased WM storage among these patients (Hahn et al. 2018). To 
conclude, the PPC is an important brain region that plays an integral role in spatial cognition. 
Additionally, the PPC appears to be involved in CNS disorders, and there is a growing pool of 
evidence that suggests that the PPC of rats is analogous in function to the PPC of primates. This 
makes the PPC of rats an intriguing target when studying the cognitive circuits underlying spatial 
working memory. 
 
1.4  Comparing the Medial Prefrontal Cortex and the Posterior Parietal Cortex 
 The mPFC and PPC are connected by the superior longitudinal fasciculus and the dorsal 
cingulum bundle, which are tracts that interconnect the frontal, parietal, and temporal lobes in 
the human brain. WM is thought to rely on circuits that connect the frontal and parietal cortices, 
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and therefore one would expect the mPFC and the PPC to contribute to spatial WM in similar 
ways. However, with multiple pathways connecting the mPFC and PPC, it would be an 
oversimplification to assume that the two brain regions share identical functions with regards to 
WM. For example, the mPFC is involved in many forms of WM, whereas the PPC seems to 
primarily be involved in spatial and visual WM (Compton et al. 1994; Berryhill and Olson 2008; 
Licata et al. 2017; Scott et al. 2019). Additionally, one group tested rats with either mPFC or 
PPC lesions on five different spatial WM tasks:  a Mumby delayed nonmatching-to-position 
(DNMP), Aggleton DNMP, Morris Water maze, Landmark Water maze, and radial arm maze 
(Kolb et al. 1994). Interestingly, rats with mPFC lesions were impaired on all five tasks, whereas 
rats with PPC lesions were only impaired in the Morris and Landmark Water mazes. Therefore, 
the mPFC and the PPC appear to have unique but important contributions to spatial WM. 
1.5 Trial Unique, Nonmatching-To-Location Task 
 In this thesis, rats were trained and tested in the automated operant-conditioned 
touchscreen TUNL task. The Trial Unique, Nonmatching-To-Location (TUNL) task is based on 
a DNMP paradigm used to test the spatial WM of rodents (Rivalan et al. 2017). It does, however, 
differ from the standard DNMP task in several ways. Typically, a DNMP task begins with a 
sample phase where rats are presented with a single lever in one of two possible positions. They 
must press against the lever, and once successful a delay period ensues. This is followed by a 
choice phase where a single lever is presented at each of the two locations. To correctly perform 
the task and receive a reward, rats must press the novel lever that was presented, otherwise 
known as the non-matched lever. This tests spatial WM because it requires the rat to encode and 
apply visual information regarding the location of the presented lever over a short delay 
(Dudchenko et al. 2013). A limitation of this task is that rats can develop mediating strategies, 
which can inflate their performance and reduce their reliance on spatial WM during the task 
(Panlilio et al. 2011). For example, rats can orient their bodies towards the to-be-correct lever 
during the delay period. Alternatively, rats can focus their attention to one lever but press down 
the opposite lever, which does not accurately reflect their choice in the task.  
 The automated operant-conditioned touchscreen TUNL task was developed in order to 
address these kinds of limitations (Rivalan et al. 2017). Like the DNMP paradigm, in TUNL 
stimuli are presented at two locations in any given trial. Unlike it, however, stimuli appear in 14 
	 5	
possible areas in a 7x2 grid of squares rather than 2 in DNMP. In order to interact with the 7x2 
grid, rats must press down a response shelf with their paws. Because of this, rats are inclined to 
nose poke and therefore draw their gaze to the illuminated stimulus. Furthermore, each stimulus 
appears randomly in 1 of the 14 possible squares, which makes it impossible to predict the 
correct location of the non-matched stimulus prior to the choice phase (Talpos et al. 2010). The 
length of the delay and the distance between sample and choice stimuli can also be manipulated 
in the TUNL task. Longer delay periods challenge WM more than shorter delay periods, and 
small distances between stimuli challenge pattern separation more than large distances between 
stimuli. Pattern separation in the context of TUNL refers to the ability to keep two similar but 
distinct patterns as separate representations within the mind (Talpos et al. 2010). Finally, the 
automated nature of the TUNL task reduces researcher bias during testing, is more time-efficient, 
and reduces variability amongst trials. 
 There is evidence that the TUNL task involves brain regions such as the mPFC, the 
hippocampus, and the PPC (Talpos et al. 2010; McAllister et al. 2013; Josey and Brigman 2015; 
Kim et al. 2015; Davies et al. 2017; Scott et al. 2019). This is consistent with the findings that all 
three of these brain areas are involved in spatial WM. Lesions to the mPFC lead to a delay-
dependent impairment in spatial WM, without an impairment in spatial pattern separation in the 
TUNL task (McAllister et al. 2013). This has been demonstrated by testing rats with either a 
minimal or a 6 s delay period, whereby mPFC-lesioned rats were only impaired in the 6 s delay 
condition. Furthermore, mPFC-lesioned rats were not impaired in small or large separations 
when a minimal delay was present. This suggested no effect on spatial pattern separation. In the 
same study, mPFC-lesioned rats also had increased susceptibility to interference as shown by 
decreased performance in a condition that utilized a minimal delay and inter-trial interval (ITI) 
compared to sham controls (McAllister et al. 2013). Unlike mPFC lesions, hippocampal lesions 
lead to both an impairment in delay-dependent WM and in pattern separation (Talpos et al. 
2010). PPC inactivation also impairs the performance of rats in the TUNL task (Scott et al. 
2019). Therefore, like many other spatial WM tasks, TUNL relies on the hippocampus, mPFC, 
and PPC. Unlike many other tasks that involve a nonmatching paradigm, however, TUNL allows 
for the careful manipulation of stimulus separations and automated randomization of delays, 
which can elucidate more specific roles of cortical regions in spatial WM. 
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1.6 Perineuronal Nets 
Perineuronal nets (PNNs) are specialized extracellular matrix structures that surround 
specific subsets of neurons throughout the central nervous system. Hyaluronan (HA) makes up 
the backbone of PNNs, and is covalently linked to chondroitin sulfate proteoglycans (CSPGs). 
This structure is stabilized by tenascin-R and various PNN link proteins, many of which are also 
found in cartilage (Deepa et al. 2006). These molecules combine to form a rigid, lattice-like 
structure that surrounds neurons, limiting structural changes and their ability to form new 
neuronal connections (Kwok et al. 2010). PNNs exist throughout the CNS in relatively low 
numbers early in development, and grow throughout postnatal life (Rogers et al. 2018). This 
growth highly coincides with the closure of critical periods, whereby synaptic plasticity is 
reduced and stabilization of a long-term synaptic network occurs (Pizzorusso et al. 2002). 
Additionally, PNNs support neurons in ion buffering, cell signaling, and in the protection against 
oxidative stress (Morawski et al. 2004; Brückner et al. 1993; Dzyubenko et al. 2016). Because of 
their supportive role, the degradation of PNNs may lead to neuronal dysfunction and cognitive 
abnormalities. This can impede learning and memory formation (Banerjee et al. 2017), or disrupt 
intact memories (Hylin et al. 2013; Xue et al. 2014). Conversely, PNN degradation can also lead 
to memory enhancements (Romberg et al. 2013). This dichotomy illustrates the complex 
relationship that PNNs have with cognition, and highlights their importance in functional 
cognition. 
Multiple CNS disorders present with abnormal PNN expression in the brain. For 
example, post-mortem analysis studies suggest that cortical PNN levels are reduced in 
schizophrenia and Alzheimer’s disease (Baig et al. 2005; Franklin et al. 2008; Mauney et al. 
2013; Enwright et al. 2016). Consistent with this, reduced cortical PNN levels have been 
observed in animal models of CNS disorders (Pollock et al. 2014; Paylor et al. 2016; Wen et al. 
2018). This is interesting, because PNNs are heterogeneous structures whose distribution varies 
based on the brain region, age, experience, and species under investigation (Shen 2018; Lensjø et 
al. 2017). PNNs exist across many vertebrate species, which implies that they play an integral 
role in the CNS. Also, PNN reductions have been observed in both animal models of CNS 
disorders and patients with CNS disorders, which make PNNs an intriguing therapeutic target.  
Over the years, many ways of targeting PNNs have been developed. Chondroitinase ABC 
(ChABC) and hyaluronidase are two enzyme treatments that acutely degrade PNNs by targeting 
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two of their major components, CSPGs and HA, respectively (Frischknecht et al. 2009). 
Interestingly, PNNs have the ability to regrow over time after ChABC and hyaluronidase 
infusions. One study tracked PNN regrowth in the primary visual cortex (V1) of Long-Evans rats 
using a Wisteria floribunda agglutinin (WFA) stain, and found that it took approximately 60 
days for the PNNs to fully regrow following ChABC infusions into the V1 (Lensjø et al. 2017).  
A significant advantage of using ChABC and hyaluronidase as treatments is that they can acutely 
degrade PNNs in a specific brain region. Unfortunately, however, these treatments do not 
specifically degrade PNNs. For example, only 2% of CSPGs (the main target of ChABC) in the 
CNS are concentrated in PNNs (Fawcett, 2015). Additionally, CSPGs have inhibitory activity 
outside of PNNs, which means that behavioural outcomes after ChABC treatment could be the 
result of a combination of CSPG and PNN degradation (Dou and Levine 1994; Jones et al. 
2003). Another way of manipulating PNNs is by targeting matrix metalloproteinases (MMPs), 
which can be endogenously expressed by PNN-ensheathed neurons (Rossier et al. 2015). MMPs 
such as MMP-9 degrade perineuronal ECM, and their levels can be modulated to either increase 
or reduce PNN levels (Gray et al. 2008). Like ChABC and hyaluronidase, MMPs target multiple 
structures in the ECM and do not specifically degrade PNNs (Bonnans et al. 2014). Some groups 
have developed knockouts of PNN components to introduce a more specific way of targeting 
PNNs. By knocking out PNN link proteins such as crtl1 in rodents, PNN development can be 
attenuated without altering CSPGs (Carulli et al. 2010). Therefore, knockout models introduce a 
specific way to target PNNs and can mimic long-term developmental deficits of PNNs as seen in 
human CNS disorders. Unfortunately, however, one notable disadvantage of these knockout 
models is that they do not specifically target a single brain region, and instead lead to whole-
brain PNN attenuation. To conclude, many different methods have been developed that alter 
PNN levels, each with their own advantages and disadvantages. Each method targets PNNs in a 
different way, and has the potential to isolate specific contributions that PNNs and other ECM 
structures have in memory and cognition. In the present study, ChABC was chosen because we 
wanted to explore the effect that acutely degrading PNNs specifically in the mPFC and PPC had 
on cognition. Furthermore, it made sense to use ChABC for the sake of consistency, because the 
present study follows up on a previous experiment in which ChABC was used to degrade PNNs 
in the mPFC (Paylor et al. 2018). 
PNN degradation in the brain has shown promise in treating some of the cognitive 
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deficits seen in rodent models of CNS dysfunction. For example, ChABC was used in two 
different rodent models of Alzheimer’s disease to restore memory. One group treated the 
perirhinal cortex of a P301S transgenic Alzheimer’s model of mice, which restored object 
recognition memory (Yang et al. 2015). Similarly, another group treated the hippocampus of an 
Alzheimer’s mouse model with mutations in its APP gene with ChABC, leading to a restoration 
of contextual memory (Végh et al. 2014). PNNs also appear to play a role in epilepsy (Rankin-
Gee et al. 2015; Pollock et al. 2014). Interestingly, ChABC treatment in a rodent epilepsy model 
increases the number of seizures that occur (Rankin-Gee et al. 2015), while MMP inhibition 
diminishes PNN degradation, leading to a reduction in seizures (Pollock et al. 2014). PNN 
degradation has also been performed in fear conditioning and drug-addiction paradigms, yielding 
unique results. ChABC infusions in the amygdala leads to the erasure of remote fear memories 
(Gogolla et al. 2009) and drug-related memories (Xue et al. 2014).  
ChABC has also been very promising in treating motor impairments caused by stroke and 
spinal cord injuries. Damage to the spinal cord can lead to glial scarring, in which inhibitory 
CSPGs are up-regulated and neural regeneration is inhibited (Spijker and Kowk 2017). ChABC 
infusions into the spinal cord not only degrade PNNs in the area, but also degrade glial scarring 
following spinal cord injury, which can promote the sprouting of intact and injured spinal 
systems and the functional recovery of limb movements (Bradbury et al. 2002; Grist et al. 2006). 
Additionally, ChABC can restore diaphragm function and normal breathing following cervical 
hemisection of rats (Warren et al. 2018). Sensimotor and limb function recovery following stroke 
was also improved by ChABC infusions into the spinal cord (Soleman et al. 2012; Wiersma et al. 
2017). In conclusion, PNNs are an important part of the ECM and contribute to normal 
physiological function. Interestingly, their levels are reduced in some CNS disorders. Studying 
the effect of brain-region specific PNN degradation can help us to understand the role of PNNs 
in cognitive circuits, and reveal a potential role of PNNs in cognitive dysfunction. 
 
1.7 Parvalbumin Expressing Neurons 
Parvalbumin (PV) is an EF-hand calcium-binding protein that is found in fast-firing nerve 
cells in the brain and fast-contracting muscles (Cates et al. 1999). PV-producing (PV+) neurons 
are one of the major subtypes of interneurons that exist in the cortex, and are found throughout 
the brain. The majority of PV+ neurons are GABAergic interneurons and are involved in the fast 
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and powerful inhibition of excitatory pyramidal cells (Celio 1986). Additionally, PV+ neurons in 
the cortex contribute to the synchronization of neuronal activity, particularly in the gamma 
frequency range (30-100Hz) (Uhlhaas et al. 2009). This synchronous oscillatory activity of 
neurons firing together plays an important role in learning and memory formation (Jutras and 
Buffalo 2010). For example, PV+ interneurons in the PFC play a crucial role in WM, attention, 
and cognitive flexibility (Murray et al. 2015; Kim et al. 2016a; Kim et al. 2016b). Furthermore, 
multiple human CNS disorders such as Alzheimer’s, autism, and schizophrenia show reductions 
in PV+ interneurons in the prefrontal cortex (Arai et al. 1987; Beasley & Reynolds 1997; 
Hashemi et al. 2017). Consistent with this, animal models of CNS disorders have reduced PV+ 
neuronal density, along with diminished oscillatory and functional activity among prefrontal 
PV+ neurons (Lodge et al. 2009; Chen et al. 2018). It has been proposed that oxidative stress on 
PV+ interneurons in the cortex can underlie the PV+ reduction and pathophysiology of some 
CNS disorders (Powell et al. 2012; Sun et al. 2016; Khan et al. 2017). Interestingly, a lack of PV 
expression levels among PV+ neurons, rather than a reduction in PV+ neuronal density, has been 
linked with reduced social interactions and communication in mice (Wöhr et al. 2015). This 
suggests that it is not only PV+ neuronal density, but also functional PV expression among PV+ 
neurons that can influence cognition.  
Different species appear to have relatively different counts of PV+ neurons in their 
brains. For example, when comparing GABA+ interneuron co-localization with calcium binding 
proteins, GABA+ interneurons in the mPFC of rats associate most with PV, whereas GABA+ 
interneurons in the mPFC of monkeys and humans associate most with calretinin (CR) (Gabbot 
et al. 1997a; Gabbot et al. 1997b; Gabbot & Bacon 1997c). Both rodents and primates have high 
levels of co-localization between PV+ neurons and PNNs in the cortex, and the maturation of 
PNNs highly coincides with that of PV+ interneurons (Härtig et al. 1992; Caballero et al. 2014). 
Like PNNs, PV+ neurons are highly regulated throughout development and are modulated in an 
experience-dependent manner (Hensch 2005). For example, physical exercise during 
adolescence leads to increased hippocampal PV expression in rodents (Gomes de Silva et al. 
2010). Additionally, a recent study found that Brevican, a core protein in PNNs, controls the 
synaptic and cellular plasticity of PV+ neurons by regulating the localization of receptors in their 
extracellular membranes (Favuzzi et al. 2017). Furthermore, PNNs support the function of PV+ 
neurons and affect their PV expression (Yamada et al. 2015; Morawaski et al. 2004; Cabungcal 
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et al. 2013). Conversely, PV+ interneurons also appear to affect PNN expression, since PV+ 
interneurons that are enwrapped in PNNs express metalloproteases that can regulate PNN density 
(Rossier et al. 2015). To conclude, it appears that PNN dysfunction can lead to dysfunction of 
the GABAergic PV+ cells that they ensheath, and that cortical PV+ neurons and PNNs appear to 
have a reciprocal and tight relationship to one another. 
 
1.8 Rationale and Hypotheses 
In the current study, the spatial WM of Long-Evans rats was tested following the 
degradation of PNNs in the mPFC and PPC. Spatial WM was measured using the automated 
touchscreen TUNL task, which was chosen because it is clinically translatable, requires little 
handling of animals during testing, and gives an accurate measure of task parameters (Talpos et 
al. 2010). Additionally, correct performance of the TUNL task relies on the mPFC and the PPC 
(McAllister et al. 2013; Scott et al. 2019). Likewise, in humans it has been suggested that the 
frontal cortex and PPC are essential for functional spatial WM, and that WM relies on intact 
fronto-parietal circuits (Courtney et al. 1998; Alekseichuk et al. 2016; Todd and Marois 2004; 
Mackey et al. 2016; Eriksson et al. 2015). The TUNL task is an effective way to measure the 
contribution of PNNs in the mPFC and PPC on the spatial WM of rats, which can give a better 
idea of how PNNs may influence human cognition. In previous studies, the knockout of PNN 
components (Montag-Sollaz and Montag 2003), as well as ChABC infusions into the mPFC 
(Paylor et al. 2018) has led to cognitive impairments. Based on this literature, we hypothesized 
that the degradation of PNNs in the mPFC and PPC would disrupt the neurological circuits that 
are required for spatial WM and impair the performance of rats in the TUNL task. More 
specifically, based on previous observations following mPFC inactivation, we predicted that 
ChABC infusions into the mPFC would impair TUNL performance in a delay-dependent 
manner, have no effect on pattern separation, and increase the susceptibility of rats to proactive 
interference (Delatour & Gisquet-Verrier 1999; McAllister et al. 2013; Hvoslef-Eide et al. 2015). 
Because spatial WM has been proposed to depend on fronto-parietal circuits (Eriksson et al. 
2015), we predicted that ChABC infusions into the PPC would also impair the performance of 
rats in TUNL. 
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2.2 Abstract 
Perineuronal nets (PNNs) are specialized extracellular matrix structures that surround subsets of 
neurons throughout the central nervous system (CNS). They are made up of chondroitin sulfate 
proteoglycans (CSPGs), hyaluronan, tenascin-R, and many other link proteins that together make 
up their rigid and lattice-like structure. Modulation of PNNs can alter synaptic plasticity and 
thereby affect learning, memory, and cognition. In the present study, we degraded PNNs in the 
medial prefrontal (mPFC) and posterior parietal (PPC) cortices of Long-Evans rats using the 
enzyme chondroitinase ABC (ChABC), which cleaves apart CSPGs. We then measured the 
consequences of PNN degradation on spatial working memory (WM) with a trial-unique, non-
matching-to location (TUNL) automated touchscreen task. All rats were trained with a standard 6 
s delay and 20 s inter-trial interval (ITI) and then tested under four different conditions: a 6 s 
delay, a variable 2 s or 6 s delay, a 2 s delay with a 1 s ITI (interference condition), and a 20 s 
delay. Rats that received mPFC ChABC treatment initially performed TUNL with higher 
accuracy, more selection trials completed, and fewer correction trials completed compared to 
controls in the 20 s delay condition, but did not perform differently from controls in any other 
condition. Rats that received PPC ChABC treatment did not perform significantly differently 
from controls in any condition. Posthumous immunohistochemistry confirmed an increase in 
CSPG degradation products (C4S stain) in the mPFC and PPC following ChABC infusions to 
those respective brain regions. These findings suggest that PNNs in the mPFC play a subtle role 
in spatial WM, but PNNs in the PPC do not. Furthermore, it appears that PNNs in the mPFC are 
involved in adapting to a challenging novel delay, but that they do not play an essential role in 
the standard TUNL task with a 6 s delay. 
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2.3 Introduction 
PNNs are part of the extracellular matrix (ECM) of the central nervous system (CNS). They are 
composed of chondroitin sulfate proteoglycans (CSPGs), hyaluronan, tenascin-R, and many link 
proteins, which make up their rigid matrix structure (Deepa et al. 2006). PNNs act as a physical 
barrier to structural changes in the neurons that they surround (Kwok et al. 2010). Additionally, 
PNNs are involved in synaptic stabilization and in the closure of critical periods of plasticity 
during development (Pizzorusso et al. 2002). The density of PNNs is relatively low early in 
development and increases throughout postnatal life (Rogers et al. 2018). Related to this, the 
removal of PNNs in adulthood can reopen periods of heightened plasticity comparable to that of 
a juvenile critical period (Lensjø et al. 2016). With such heightened plasticity comes potential 
reorganization of neuronal structure, connectivity, and function (Pizzorusso et al. 2002). 
 PNNs appear to be involved with learning and memory in the adult brain, and PNN 
degradation in the brain can lead to changes in behaviour and cognition (Gogolla et al. 2009; Lee 
et al. 2012; Xue et al. 2014; Happel et al. 2014; Thompson et al. 2018; Lasek et al. 2018; Paylor 
et al. 2018). A common method of degrading PNNs is by targeting CSPGs with the enzyme 
chondroitinase ABC (ChABC) (Lee et al. 2009). Interestingly, the cognitive and behavioural 
changes following ChABC infusions depend on the location and timing of treatment (Shen 
2018). For example, the infusion of ChABC into the perirhinal cortex enhances recognition 
memory in an object recognition paradigm (Romberg et al. 2013). Conversely, the infusion of 
ChABC into the medial prefrontal cortex (mPFC) leads to impaired cross-modal object 
recognition and object oddity tests (Paylor et al. 2018). Furthermore, PNN distribution in the 
CNS varies between species, and therefore PNN disruptions may cause varied behavioural 
effects across different animal models (Lensjø et al. 2017). However, the conservation of PNNs 
across many vertebrate species implies that they play an integral and similar function in the CNS. 
Additionally, reductions in cortical PNNs have been observed in patients with schizophrenia and 
Alzheimer’s disease (Baig et al. 2005; Mauney et al. 2013; Enwright et al. 2016) and in animal 
models of stroke, prion diseases, epilepsy, and schizophrenia (Hobohm et al. 2005; Franklin et 
al. 2008; McRae et al. 2012; Paylor et al. 2016). Continued investigation of how PNNs 
contribute to cognition in adults can help us to discover whether there is a link between 
abnormalities in PNN distribution and the cognitive deficits seen in these CNS disorders. 
In the current study, the spatial working memory (WM) of Long-Evans rats was tested 
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following the degradation of PNNs in the mPFC and posterior parietal cortex (PPC). Spatial WM 
was measured using the automated touchscreen trial-unique, non-matching-to location (TUNL) 
task, which was chosen because it is clinically translatable, requires little handling of animals 
during testing, and gives an accurate measure of task parameters (Talpos et al. 2010). 
Performance of the TUNL task relies on the mPFC and the PPC (McAllister et al. 2013; Scott et 
al. 2019). Likewise, in humans it has been suggested that the frontal cortex and PPC are essential 
for functional spatial WM, and that WM relies on intact fronto-parietal circuits (Courtney et al. 
1998; Alekseichuk et al. 2016; Todd and Marois 2004; Mackey et al. 2016; Eriksson et al. 2015). 
In our previous study, ChABC infusions into the mPFC led to cognitive impairments (Paylor et 
al. 2018). Based on these findings, we hypothesized that the degradation of PNNs in the mPFC 
and PPC would disrupt the neurological circuits that are required for spatial WM and impair the 
performance of rats in the TUNL task.  
 
2.4 Results 
 Rats were trained in the TUNL task (Figures 1 & 2) until they reached a minimum group 
average of 50 trials at 65% accuracy using a 6 s delay. Surgeries were then performed, infusing 
penicillinase (PEN) control or ChABC into the mPFC of one cohort of rats and into the PPC of 
another cohort of rats. After 5-10 days of recovery, rats were tested in TUNL under 4 different 
conditions: a 6 s delay, a variable 2 s or 6 s delay, a 2 s delay with a 1 s ITI (interference 
condition), and a 20 s delay (Figure 1). 
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  		  Figure 1.1:  Schem
atic of the training and testing schedule. D
uring the training phase, rats w
ere trained on TU
N
L to criterion. 
Chondroitinase A
BC or penicillinase w
as then locally infused into m
edial prefrontal cortex or posterior parietal cortex. Follow
ing 
recovery, rats w
ere re-tested for 3 days on the standard TU
N
L task that they w
ere trained on pre- surgery (Condition 1). D
uring 
Condition 2, a variable delay 2- or 6- second delay w
as used to assess w
orking m
em
ory. Condition 3 w
as designed as an interference 
task w
ith a 1-second, instead of the standard 20- second, ITI betw
een trials. Condition 4 introduced a novel challenging delay of 20 s.
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Figure 1.2: (A) Schematic showing the progression of a TUNL trial. The standard TUNL task 
that rats are trained on uses a 6 s delay and a 20 s ITI, but the length of both of these periods can 
be altered. (B) Schematic of a Long Evans rat performing the testing phase of the TUNL task. 
(C) Schematic labeling distances between stimuli in the testing phase as large (4-5 squares 
away), intermediate (3 squares away), or small (1-2 squares away). Stimuli within the testing 
phase of a trial are not presented horizontally, vertically, or diagonally adjacent to one another. 
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2.4.1 ChABC infusions into the mPFC improve performance of the TUNL task with a 20 s 
delay 
ChABC infusions in the mPFC had no effect on the performance of rats in condition 1 (6 s delay) 
A mixed 2x2 ANOVA (treatment, separation) revealed that the accuracy of PEN and 
ChABC-treated rats was not significantly different (Fig. 3A; F(1,21) = 0.00, p = 0.99). The 
percent accuracy of rats was higher on trials with large stimulus separations compared to trials 
with small stimulus separations (F(1,21) = 101.31, p < 0.001), and there was no interaction 
between stimulus separation and treatment (F(1,21) = 0.12, p = 0.73). Independent-samples t-
tests revealed that ChABC-treated rats did not perform significantly differently from PEN-
treated rats in terms of total trials completed (Fig. 3B; t(21) = 0.60, p = 0.56), selection trials 
completed (Fig. 3C; t(21) = 0.67, p = 0.51), correction trials completed (Fig. 3D; t(21) = -0.117, 
p = 0.91), or reward latency (Fig. 3E; t(21) = 0.51, p = 0.62). A mixed 2x2 ANOVA (treatment, 
latency type) revealed that there was no difference in the correct and incorrect trial latency of 
ChABC-treated versus PEN-treated rats (Fig. 3F; F(1,21) = 0.11, p = 0.74), but that the incorrect 
trial latency was significantly longer than the correct trial latency (F(1,21) = 15.86, p = 0.001). 
There was no significant interaction between treatment and latency type (F(1,21) = 1.61, p = 
0.22). 
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Figure 1.3: Effects of PEN or ChABC infusions into the mPFC on TUNL with a 6 s delay 
(Condition 1). All values represent the average (Mean ± SEM) of the testing days (A) ChABC 
had no effect on accuracy. Accuracy was significantly higher on trials with large stimulus 
separations compared to trials with small stimulus separations. (B) ChABC had no effect on the 
total number of trials completed. (C) ChABC had no effect on the number of selection trials 
completed. (D) ChABC had no effect on the number of correction trials completed. (E) ChABC 
had no effect on reward latency. (F) ChABC had no effect on the latency of correct and incorrect 
trials. Incorrect latency was significantly longer than correct latency. PEN, n = 12; ChABC, n = 
11; *p <0.05. 
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ChABC infusions in the mPFC had no effect on the performance of rats in condition 2 (variable 
2 s or 6 s delay) 
A mixed three-way ANOVA (treatment, separation, delay) revealed no significant 
differences in percent accuracy between ChABC and PEN-treated rats (Fig. 4A; F(1,21) = 0.07, p 
= 0.80). However, main effects of separation (F(1,21) = 8.64, p = 0.008) and delay (F(1,21) = 
131.32, p < 0.001) were found, as well as a significant interaction between the two factors 
(F(1,21) = 87.12, p < 0.001). Post hoc analyses using Tukey’s method revealed that the percent 
accuracy on trials with a 2 s delay and small stimulus separations was significantly greater than 
any other combination of delay and separation (p < 0.05). Additionally, the percent accuracy on 
trials with a 2 s delay and small stimulus separations was not significantly different than that of 
trials with a 6 s delay and small stimulus separation (p > 0.05), but both were significantly 
different from that of trials with a 6 s delay and large stimulus separation (p < 0.05) (Fig. 4A). 
There were no significant interactions between treatment and delay (F(1,21) = 0.16, p = 0.69), 
treatment and separation distance (F(1,21) = 0.00, p = 0.95), or treatment x delay x separation 
distance (F(1,21) = 0.39, p = 0.54). 
Independent-samples t-tests revealed that ChABC-treated rats did not perform 
significantly differently from PEN-treated rats in terms of total trials completed (Fig. 4B; t(21) = 
1.18, p = 0.25), selection trials completed (Fig. 4C; t(21) = 1.43, p = 0.17), correction trials 
completed (Fig. 4D; t(21) = 0.22, p = 0.83), or reward latency (Fig. 4E; t(21) = -0.272, p = 0.79). 
A mixed 2x2 ANOVA (treatment, separation) revealed no significant difference in the correct 
and incorrect trial latency of ChABC-treated versus PEN-treated rats (Fig. 4F; F(1,21) = 0.81, p 
= 0.38), but the incorrect trial latency was significantly longer than the correct trial latency 
(F(1,21) = 16.17, p = 0.001). There was no significant interaction between treatment and latency 
type (F(1,21) = 1.38, p = 0.25). 
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Figure 1.4: Effects of PEN or ChABC infusions into the mPFC on TUNL with a variable 2 s or 6 
s delay (Condition 2). All values represent the average (Mean ± SEM) of the testing days. (A) 
Percent accuracy on trials with either a 2 s delay and large stimulus separation, 2 s delay and 
small stimulus separation, 6s delay and large stimulus separation, and 6 s delay and small 
stimulus separation. ChABC had no effect on percent accuracy. Percent accuracy on trials with a 
2 s delay and a large stimulus separation was significantly higher than any other group. Percent 
accuracies on trials with a 2 s and 6 s delay with small stimulus separations were not 
significantly different from one another, but were both significantly higher than percent accuracy 
on trials with a 6 s delay and a large stimulus separation. (B) ChABC had no effect on the total 
number of trials completed. (C) ChABC had no effect on the number of selection trials 
completed. (D) ChABC had no effect on the number of correction trials completed. (E) ChABC 
had no effect on reward latency. (F) ChABC had no effect on correct or incorrect latency. 
Incorrect latency was significantly longer than correct latency. PEN, n = 12; ChABC, n = 11; # 
significantly different from all other groups (p < 0.05); *p < 0.05. 
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ChABC infusions in the mPFC had no effect on the performance of rats in condition 3 (2 s delay 
with a 1 s inter-trial interval) 
A mixed 2x2 ANOVA (treatment, separation) revealed that the percent accuracy of 
ChABC-treated rats was not significantly different than that of PEN-treated rats (Fig. 5A; F(1,21) 
= 0.00, p = 0.94). However, the percent accuracy of rats was significantly higher on large 
separation trials compared to small separation trials (F(1,21) = 189.54, p < 0.001), with a 
significant interaction existing between stimulus separation and treatment (F(1,21) = 5.46, p = 
0.029). Independent-samples t-tests revealed that ChABC-treated rats did not perform 
significantly differently from PEN-treated rats in terms of total trials completed (Fig. 5B; t(21) = 
-0.41, p = 0.68), selection trials completed (Fig. 5C; t(21) = -0.33, p = 0.75), correction trials 
completed (Fig. 5D; t(21) = -0.27, p = 0.79), or reward latency (Fig. 5E; t(21) = -0.14, p = 0.89). 
A mixed 2x2 ANOVA (treatment, latency type) revealed no significant difference in the correct 
and incorrect trial latency of ChABC-treated versus PEN-treated rats (Fig. 5F; F(1,21) = 0.45, p 
= 0.51), but that the incorrect trial latency was significantly longer than the correct trial latency 
(F(1,21) = 13.62, p = 0.001). There was no significant interaction between treatment and latency 
type (F(1,21) = 1.49, p = 0.24).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	22	
	
 
Figure 1.5: Effects of PEN or ChABC infusions into the mPFC on TUNL with a 2 s delay and a 
1 s ITI (Condition 3). All values represent the average (Mean ± SEM) of the testing days. (A) 
ChABC had no effect on percent accuracy. Percent accuracy on trials with large stimulus 
separations was significantly higher than percent accuracy on trials with small stimulus 
separations. (B) ChABC had no effect on the total number of trials completed. (C) ChABC had 
no effect on the number of selection trials completed. (D) ChABC had no effect on the number 
of correction trials completed. (E) ChABC had no effect on reward latency. (F) ChABC had no 
effect on correct or incorrect latency. Incorrect latency was significantly longer than correct 
latency. PEN, n = 12; ChABC, n = 11; *p < 0.05. 
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ChABC infusions in the mPFC improved performance of rats in condition 4 on the first two 
testing days (20 s delay) 
 Overall accuracy, accuracy at large stimulus separations, accuracy at small stimulus 
separations, total trials completed, selection trials completed, and correction trials completed 
were analyzed with mixed 2x3 ANOVAs (treatment, testing day). Overall percent accuracy was 
not significantly different between PEN and ChABC-treated rats (Fig. 6A; F(1,21) = 3.00, p = 
0.10). Additionally, there was no main effect of testing day (F(2,42) = 2.66, p = 0.08), and no 
interaction between treatment and testing day (F(2,42) = 1.19, p = 0.32). The percent accuracy 
for trials with large stimulus separations was not significantly different between PEN and 
ChABC-treated rats (Fig. 6B; F(1,21) = 1.60, p = 0.22). Furthermore, there was no main effect of 
testing day (F(2,42) = 1.60, p = 0.21) and no interaction between treatment and testing day 
(F(2,42) = 2.30, p = 0.11). The percent accuracy for trials with small stimulus separations was 
not significantly different between PEN and ChABC-treated rats (Fig. 6C; F(1,21) = 2.14, p = 
0.16). There was also was no main effect of testing day (F(2,42) = 1.13, p = 0.33), and no 
interaction between treatment and testing day (F(2,42) = 0.42, p = 0.66). 
 There was no significant difference in the number of total trials completed by PEN and 
ChABC-treated rats (Fig. 6D; F(1,21) = 2.93, p = 0.10). Additionally, there was no main effect 
of testing day (F(2,42) = 0.69, p = 0.51), and no interaction between treatment and testing day 
(F(2,42) = 2.15, p = 0.13). There was also no significant difference in the number of selection 
trials completed by PEN and ChABC-treated rats (Fig. 6E; F(1,21) = 0.42, p = 0.53). However, 
there was a significant main effect of testing day (F(2,42) = 9.95, p < 0.001), and a significant 
interaction between treatment and testing day (F(2,42) = 4.37, p = 0.019). Post hoc analyses 
using Tukey’s method revealed that rats performed significantly more mean selection trials on 
testing days 12-13 compared to testing days 10-11 (p < 0.05), as well as significantly more mean 
selection trials on testing days 14-15 compared to testing day 10-11 (p < 0.05).  
 There was no difference in the number of correction trials completed by PEN and 
ChABC-treated rats (Fig. 6F; F(1,21) = 3.60, p = 0.07). There was, however, a significant main 
effect of testing day (F(2,42) = 15.53, p < 0.001), but no interaction between treatment and 
testing day (F(2,42) = 2.69, p = 0.079). Post hoc analyses using Tukey’s method revealed that 
rats performed fewer correction trials on testing days 12-13 (p < 0.05) and 14-15 (p < 0.05) 
compared to testing days 10-11. 
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 An independent-samples t-test revealed that PEN and ChABC-treated rats did not have 
any significant differences in reward latency (Fig. 6G; t(21) = -0.30, p = 0.77). A mixed 2x2 
ANOVA (treatment, latency type) revealed no significant difference in the correct and incorrect 
trial latency of ChABC-treated versus PEN-treated rats (Fig. 6H; F(1,21) = 0.82, p = 0.38), but 
the incorrect trial latency was significantly longer than the correct trial latency (F(1,21) = 9.34, p 
= 0.006). There was no interaction between treatment and latency type (F(1,21) = 2.59, p = 0.12). 
 When investigating the initial two days of the 20 s delay condition (testing days 10-11), 
independent samples t-tests revealed that ChABC-treated rats initially had a higher total percent 
accuracy (Fig. 6A; t(21) = -3.38, p = 0.003), higher large separation percent accuracy (Fig. 6B; 
t(21) = -2.74, p = 0.012), more selection trials completed (Fig. 6E; t(21) = -2.31, p = 0.031), and 
fewer correction trials completed (Fig. 6F; t(21) = 3.52, p = 0.002) compared to PEN-treated 
rats. There were no significant differences in small separation percent accuracy (Fig. 6C; t(21) = 
-1.528, p = 0.14), total trials completed (Fig. 6D; t(21) = 0.92, p = 0.37) between ChABC-treated 
rats and PEN-treated rats over the first 2 days of the 20 s delay.  
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Figure 1.6: Effects of PEN or ChABC infusions into the mPFC on TUNL with a 20 s delay 
period (Condition 4). All values represent the average (Mean ± SEM) of the testing days. (A) 
ChABC-treated rats had a significantly higher overall percent accuracy than PEN-treated rats 
over the first two days of testing, but not over the full six days of testing. (B) ChABC-treated rats 
had a significantly higher percent accuracy on trials with large stimulus separations compared to 
PEN-treated rats over the first two days of testing, but not over the full six days of testing. (C) 
ChABC had no effect on percent accuracy in trials with small stimulus separations. (D) ChABC 
had no effect on the number of total trials completed. (E) ChABC-treated rats completed 
significantly more selection trials than PEN-treated rats over the first two days of testing, but not 
over the full six days of testing. Rats performed significantly more selection trials on testing days 
12-13 and 14-15 compared to testing days 10-11. (F) ChABC-treated rats completed 
significantly fewer correction trials than PEN-treated rats over the first two days of testing, but 
not over the full six days of testing. Rats performed significantly fewer correction trials on 
testing days 12-13 and 14-15 compared to testing days 10-11 (G) ChABC had no effect on 
reward latency. (H) ChABC had no effect on correct or incorrect latency. Incorrect choice 
latency was significantly higher than correct choice latency. ChABC infusions had no effect on 
reward latency. PEN, n = 12; ChABC, n = 11; *p < 0.05.	
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2.4.2 ChABC infusions into the PPC does not alter performance of rats in the TUNL task	
ChABC infusions in the PPC had no effect on the performance of rats in condition 1 (6 s delay) 
 A mixed 2x2 ANOVA (treatment, separation) revealed that the accuracy of PEN and 
ChABC-treated rats was not significantly different (Fig. 7A; F(1,22) = 3.48, p = 0.08). Rats 
performed better on trials with large stimulus separations compared to trials with small stimulus 
separations (F(1,22) = 18.34, p < 0.001), and there was no interaction between stimulus 
separation and treatment (F(1,22) = 0.25, p = 0.62). Independent-samples t-tests revealed that 
ChABC-treated rats did not perform significantly differently from PEN-treated rats in terms of 
total trials completed (Fig. 7B; t(22) = 0.93, p = 0.36), selection trials completed (Fig. 7C; t(22) = 
1.29, p = 0.21), correction trials completed (Fig. 7D; t(22) = -0.12, p = 0.91), or reward latency 
(Fig. 7E; t(22) = -1.76, p = 0.09). Additionally, a mixed 2x2 ANOVA (treatment, latency type) 
revealed that there was no difference in the correct and incorrect trial latency of ChABC-treated 
versus PEN-treated rats (Fig. 7F; F(1,22) = 0.73, p = 0.40), and that the there was no difference 
in correct and incorrect trial latencies (F(1,22) = 2.50, p = 0.13). There was no significant 
interaction between treatment and latency type (F(1,22) = 0.20, p = 0.66). 
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Figure 1.7: Effects of PEN or ChABC infusions into the PPC on TUNL with a 6 s delay 
(Condition 1). All values represent the average (Mean ± SEM) of the testing days. (A) ChABC 
had no effect on accuracy. Accuracy was significantly higher on trials with large stimulus 
separations compared to trials with small stimulus separations. (B) ChABC had no effect on the 
total number of trials completed. (C) ChABC had no effect on the number of selection trials 
completed. (D) ChABC had no effect on the number of correction trials completed. (E) ChABC 
had no effect on reward latency. (F) ChABC had no effect on the latency of correct and incorrect 
trials. There was no difference in correct and incorrect latency. PEN, n = 12; ChABC, n = 12; *p 
< 0.05. 
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ChABC infusions in the PPC had no effect on the performance of rats in condition 2 (variable 2 s 
or 6 s delay) 
A mixed three-way ANOVA (treatment, separation, delay) revealed no significant 
differences between ChABC and PEN-treated rats (Fig. 8A; F(1,22) = 0.00, p = 0.96). There was 
also no significant main effect of separation (F(1,22) = 2.23, p = 0.14), but there was a 
significant main effect of delay (F(1,22) = 145.69, p < 0.001) as well as an interaction between 
the two was observed (F(1,21) = 87.12, p < 0.001). Additionally, there was a significant 
interaction between separation distance and delay (F(1,22) = 46.66, p < 0.001). Post hoc analyses 
using Tukey’s method revealed that the percent accuracy on trials with a 2 s delay and small 
stimulus separations was significantly higher than any other combination of delay and separation 
(p < 0.05). Additionally, the percent accuracy on trials with a 2 s delay and small stimulus 
separations was also significantly different from trials with a 6 s delay and large stimulus 
separation (p < 0.05), but was not significantly different than that of trials with a 6 s delay and 
small stimulus separation (p > 0.05). Percent accuracy on trials with a 6 s delay and a small 
stimulus separation was also significantly different from that on trials with a 6 s delay and large 
stimulus separations (p < 0.05). There were no significant interactions between treatment and 
delay (Fig. 8A; F(1,22) = 0.03, p = 0.86), treatment and separation distance (F(1,22) = 0.00, p = 
0.99), or treatment x delay x separation distance (F(1,22) = 0.02, p = 0.89). 
Furthermore, independent-samples t-tests revealed that ChABC-treated rats did not 
perform significantly differently from PEN-treated rats in terms of total trials completed (Fig. 
8B; t(22) = 1.11, p = 0.28), selection trials completed (Fig. 8C; t(22) = 0.79, p = 0.44), correction 
trials completed (Fig. 8D; t(22) = 0.90, p = 0.38), or reward latency (Fig. 8E; t(22) = -1.91, p = 
0.07).  
A mixed 2x2 ANOVA (treatment, latency type) revealed no significant difference in the 
correct and incorrect trial latency of ChABC-treated versus PEN-treated rats (Fig. 8F; F(1,22) = 
0.65, p = 0.43), but the incorrect trial latency was significantly longer than the correct trial 
latency (F(1,22) = 6.23, p = 0.02). There was no significant interaction between treatment and 
latency type (F(1,22) = 0.48, p = 0.49). 
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Figure 1.8: Effects of PEN or ChABC infusions into the PPC on TUNL with a variable 2 s or 6 s 
delay (Condition 2). All values represent the average (Mean ± SEM) of the testing days. (A) 
Percent accuracy on trials with either a 2 s delay and large stimulus separation, 2 s delay and 
small stimulus separation, 6 s delay and large stimulus separation, and 6 s delay and small 
stimulus separation. ChABC had no effect on percent accuracy. Percent accuracy on trials with a 
2 s delay and a large stimulus separation was significantly higher than any other group. Percent 
accuracies on trials with a 2 s and 6 s delay with small stimulus separations were not 
significantly different from one another, but were both significantly higher than percent accuracy 
on trials with a 6 s delay and a large stimulus separation. (B) ChABC had no effect on the total 
number of trials completed. (C) ChABC had no effect on the number of selection trials 
completed. (D) ChABC had no effect on the number of correction trials completed. (E) ChABC 
had no effect on reward latency. (F) ChABC had no effect on correct or incorrect latency. 
Incorrect latency was significantly longer than correct latency. PEN, n = 12; ChABC, n = 12; # 
significantly different from all other groups (p < 0.001); *p < 0.05. 
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ChABC infusions in the PPC had no effect on the performance of rats in condition 3 (2 s delay 
with a 1 s inter-trial interval) 
 
A mixed 2x2 ANOVA (treatment, separation) revealed that the percent accuracy of 
ChABC-treated rats was not significantly different than that of PEN-treated rats (Fig. 9A; F(1,22) 
= 0.20, p = 0.66). Rats, however, did perform significantly better on large separation trials 
compared to small separation trials (F(1,22) = 25.36, p < 0.001), but there was no significant 
interaction between stimulus separation and treatment (F(1,22) = 0.16, p = 0.70). Furthermore, 
independent-samples t-tests revealed that ChABC-treated rats did not perform significantly 
differently from PEN-treated rats in terms of total trials completed (Fig. 9B; t(22) = 1.75, p = 
0.09), selection trials completed (Fig. 9C; t(22) = 1.49, p = 0.15), correction trials completed 
(Fig. 9D; t(22) = 0.70, p = 0.49), or reward latency (Fig. 9E; t(22) = -1.58, p = 0.13). 
A mixed 2x2 ANOVA (treatment, latency type) revealed no significant difference in the correct 
and incorrect trial latency of ChABC-treated versus PEN-treated rats (Fig. 9F; F(1,22) = 0.11, p 
= 0.75), but that the incorrect trial latency was significantly longer than the correct trial latency 
(F(1,22) = 21.88, p < 0.001). There was no significant interaction between treatment and latency 
type (F(1,22) = 0.00, p = 0.99). 
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Figure 1.9: Effects of PEN or ChABC infusions into the PPC on TUNL with a 2 s delay and a 1 s 
ITI (Condition 3). All values represent the average (Mean ± SEM) of the testing days. (A) 
ChABC had no effect on percent accuracy. Percent accuracy on trials with large stimulus 
separations was significantly higher than percent accuracy on trials with small stimulus 
separations. (B) ChABC had no effect on the total number of trials completed. (C) ChABC had 
no effect on the number of selection trials completed. (D) ChABC had no effect on the number 
of correction trials completed. (E) ChABC had no effect on reward latency. (F) ChABC had no 
effect on correct or incorrect latency. Incorrect latency was significantly longer than correct 
latency. PEN, n = 12; ChABC, n = 12; *p < 0.05. 
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ChABC infusions in the PPC had no effect on the performance of rats in condition 4 (20 s delay) 
Overall accuracy, accuracy at large stimulus separations, accuracy at small stimulus 
separations, total trials completed, selection trials completed, and correction trials completed 
were analyzed with mixed 2x3 ANOVAs (treatment, testing day). Overall accuracy was not 
significantly different between PEN and ChABC-treated rats (Fig. 10A; F(1,22) = 0.25, p = 
0.62). Additionally, there was no main effect of testing day (F(2,44) = 0.59, p = 0.56), and no 
interaction between treatment and testing day (F(2,44) = 0.20, p = 0.82). The percent accuracy 
for trials with large stimulus separations was not significantly different between PEN and 
ChABC-treated rats (Fig. 10B; F(1,22) = 2.92, p = 0.10). Furthermore, there was no main effect 
of testing day (F(2,44) = 0.64, p = 0.54) and no interaction between treatment and testing day 
(F(2,44) = 0.94, p = 0.40). The percent accuracy for trials with small stimulus separations was 
not significantly different between PEN and ChABC-treated rats (Fig. 10C; F(1,22) = 0.93, p = 
0.35). There was also was no main effect of testing day (F(2,44) = 0.35, p = 0.71), and no 
interaction between treatment and testing day (F(2,44) = 0.28, p = 0.76). 
 There was no difference in the number of total trials completed by PEN and ChABC-
treated rats (Fig. 10D; F(1,22) = 0.97, p = 0.34). However, there was a main effect of testing day 
(F(2,44) = 4.19, p = 0.022), but no interaction between treatment and testing day (F(2,44) = 0.98, 
p = 0.39). Post hoc analyses using Tukey’s method revealed that rats performed significantly 
more mean total trials on days 5-6 compared to days 1-2 (p < 0.05). 
There was also no difference in the number of selection trials completed by PEN and 
ChABC-treated rats (Fig. 10E; F(1,22) = 0.06, p = 0.81). There was, however, a significant main 
effect of testing day (F(2,44) = 9.21, p < 0.001), but no interaction between treatment and testing 
day (F(2,44) = 0.62, p = 0.55). Post hoc analyses using Tukey’s method revealed that rats 
performed significantly more mean selection trials on days 5-6 compared to days 1-2 (p < 0.05). 
There was no difference in the number of correction trials completed by PEN and 
ChABC-treated rats (Fig. 10F; F(1,22) = 1.52, p = 0.23). There was also no significant main 
effect of testing day (F(2,44) = 0.46, p = 0.63) and no interaction between treatment and testing 
day (F(2,44) = 0.22, p = 0.81). 
An independent samples t-test revealed that PEN and ChABC-treated rats did not have 
any significant differences in reward latency (Fig. 10G; t(22) = -1.43, p = 0.17). A mixed 2x2 
ANOVA (treatment, latency type) revealed no significant difference in the correct and incorrect 
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trial latency of ChABC-treated versus PEN-treated rats (Fig. 10H; F(1,22) = 0.19, p = 0.66), 
Additionally, there was no difference between correct trial latency and incorrect trial latency  
(F(1,22) = 0.14, p = 0.72), as well as no interaction between treatment and latency type (F(1,22) 
= 2.67, p = 0.12). 
 When investigating the initial two days of the 20 s delay condition (testing days 10-11), 
independent samples t-tests revealed that there were no significant differences between PEN and 
ChABC-treated rats with regards to total percent accuracy (Fig. 10A; t(22) = -0.39, p = 0.70), 
large separation percent accuracy (Fig. 10B; t(22) = -0.49, p = 0.63), small separation percent 
accuracy (Fig. 10C; t(22) = 0.50, p = 0.62), total trials completed (Fig. 10D; t(22) = 0.09, p = 
0.93), selection trials completed (Fig. 10E; t(22) = -0.46, p = 0.65), or correction trials completed 
(Fig. 10F; t(22) = 0.58, p = 0.57). 
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Figure 1.10: Effects of PEN or ChABC infusions into the PPC on TUNL with a delay of 20 s 
(Condition 4). All values represent the average (Mean ± SEM) of the testing days. (A) ChABC 
had no effect on overall percent accuracy. (B) ChABC had no effect on the percent accuracy on 
trials with large stimulus separations. (C) ChABC had no effect on the percent accuracy on trials 
with small stimulus separations. (D) ChABC had no effect on the total number of trials 
completed. Rats performed significantly more total trials on testing days 14-15 compared to 
testing days 10-11. (E) ChABC had no effect on the number of selection trials completed. Rats 
performed significantly more selection trials on testing days 14-15 compared to testing days 10-
11. (F) ChABC had no effect on the number of correction trials completed. (G) ChABC had no 
effect on reward latency. (H) ChABC had no effect on correct or incorrect latency. PEN, n = 12; 
ChABC, n = 12; *p < 0.05. 
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2.4.3 Quantification of the effects of ChABC on PNNs in the mPFC 
To confirm the degradation of CSPGs and PNNs by ChABC in the mPFC, we stained 
with Wisteria Floribunda Agglutinin (WFA), a marker for CSPGs that preferentially labels 
PNNs, and mouse anti-chondroitin-4-sulfate (C4S), a marker for cleaved components of CSPGs. 
WFA intensity was significantly reduced within the mPFC of ChABC-treated rats compared to 
controls (Fig. 11D; t(21) = 3.78, p= 0.001). Staining intensity for C4S was significantly higher 
within the mPFC of ChABC-treated rats than in controls (Fig. 11E; t(21) = -3.81, p= 0.001). As a 
control reference region, the somatosensory jaw area (S1J) was assessed. In this region, there 
was no difference in WFA (Fig. 11D; t(21) = 1.89, p= 0.07) or C4S (Fig. 11E; t(21) = -0.79, p= 
0.44) intensities compared to controls.  
 PNNs commonly ensheathe parvalbumin containing (PV+) inhibitory interneurons in the 
cortex (Härtig et al., 1992). To assess whether degradation of PNNs was paired with PV+ 
interneuron loss, staining with an antibody specific to PV+ was performed. PNN counts (Fig. 
12E; t(21) = 3.129, p= 0.005), PV+ cell counts (Fig. 12F; t(21) = 2.39, p= 0.027), and the 
percentage of PV+ cells surrounded by PNNs (Fig. 12G; t(21) = 2.23, p= 0.037) were all 
significantly reduced in ChABC-treated rats compared to controls. 
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Figure 1.11: ChABC infusions into the mPFC decreased WFA expression of the extracellular 
matrix and increased C4S staining for cleaved CSPG stubs. Representative images captured at 
10x magnification of (A) DAPI, (B) WFA, and (C) C4S. (D) ChABC infusions into the mPFC 
significantly reduced WFA expression in the mPFC, but not in the lateral S1 reference region. 
(E) ChABC infusions into the mPFC significantly increased the expression of C4S in the mPFC, 
but had no effect within the S1 reference region. Scale bar (white): 100μm; PEN, n = 12; 
ChABC, n = 11; *p < 0.05. 
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Figure 1.12: ChABC infusions into the mPFC reduced PV+ cell density but did not affect PNN 
density. Representative images captured at 10x magnification of (A) DAPI, (B) WFA, (C) PV+, 
and (D) merged images. (E) PNN count was significantly reduced following ChABC infusions 
(F) PV+ cell count was significantly reduced following ChABC infusions. (G) ChABC-treated 
animals had significantly fewer PV+ cells surrounded by PNNs compared to controls. Scale bar 
(white): 100μm; PEN, n = 12; ChABC, n = 11; *p < 0.05.  		
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2.4.4 Quantification of the effects of ChABC on PNNs in the PPC 
Staining intensity for C4S was significantly higher within the PPC of ChABC-treated rats 
than in controls (Fig. 13D; t(22) = -2.46, p= 0.022). WFA intensity, however, was not 
significantly different within the PPC of ChABC-treated rats compared to controls (Fig. 13E; 
t(22) = 0.83, p= 0.42). As a control reference region, an area lateral to the PPC was chosen. In 
this region, there was no difference in WFA (Fig. 13D; t(22) = 0.43, p= 0.68) or C4S (Fig. 13E; 
t(22) = 0.35, p= 0.73) intensities compared to controls.  
 Like the protocol for the mPFC, the number of PV+ cells and PNNs was also assessed in 
the PPC. ChABC-treated rats were not significantly different than controls in terms of PNN 
count (Fig. 14E; t(21) = 0.424, p= 0.676), PV+ cell count (Fig. 14F; t(21) = -0.08, p= 0.94), or 
the percentage of PV+ cells surrounded by PNNs (Fig. 14G; t(21) = -0.03, p= 0.97). 
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Figure 1.13: ChABC infusions into the PPC increased C4S staining for cleaved CSPG stubs but 
had no effect on WFA intensity. Representative images captured at 10x magnification of (A) 
DAPI, (B) WFA, and (C) C4S. (D) ChABC infusions into the PPC had no effect on WFA 
expression in the PPC or in a reference region lateral to the PPC. (E) ChABC infusions into the 
PPC significantly increased the expression of C4S in the PPC, but had no effect within a 
reference region lateral to the PPC. Scale bar (white): 100μm; PEN, n = 12; ChABC, n = 12; *p 
< 0.05. 
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Figure 1.14: ChABC infusions into the PPC did not reduce PNN density or PV+ cell density. 
Representative images captured at 10x magnification of (A) DAPI, (B) WFA, (C) PV+, and (D) 
merged images. (E) ChABC infusions into the PPC had no effect on PNN count (F) ChABC 
infusions into the PPC had no effect on PV+ cell count (G) ChABC infusions into the PPC had 
no effect on the percent of PV+ cells surrounded by PNNs. Scale bar (white): 100μm; PEN, n = 
11; ChABC, n = 12. 
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2.4.5 PNN regrowth in the mPFC following ChABC treatment 
 WFA intensity was normalized for each rat by using S1 as a control reference region. 
PEN-treated rats that were sacrificed 30 days after surgery had a significantly higher normalized 
WFA intensity than ChABC-treated rats that were sacrificed 7 days after surgery (Fig. 15; t(14) 
= 3.66, p = 0.003) and 30 days after surgery (t(21) = 3.23, p = 0.004). Additionally, ChABC-
treated rats that were sacrificed 30 days after surgery had a significantly higher normalized WFA 
intensity than ChABC-treated rats that were sacrificed 7 days after surgery (t(13) = 4.13, p = 
0.001). 
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Figure 1.15:  Comparison of normalized WFA intensities of rats that were sacrificed that were 
sacrificed 30 after mPFC PEN infusions and rats that were sacrificed 7 or 30 days after mPFC 
ChABC infusions. WFA intensity was normalized for each rat by using S1 as a control reference 
region. PEN-treated rats that were sacrificed 30 days after surgery had a significantly higher 
normalized WFA intensity than ChABC-treated rats that were sacrificed 7 days after surgery and 
30 days after surgery. ChABC-treated rats that were sacrificed 7 days after surgery had a 
significantly higher normalized WFA intensity than ChABC-treated rats that were sacrificed 30 
days after surgery. ChABC 7, n = 4; ChABC 30, n = 11; PEN 30, n = 12; * significantly different 
from all other groups (p < 0.05). 	
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2.5 Discussion 
 Targeted delivery of ChABC into the mPFC and PPC was performed to degrade CSPGs 
and PNNs prior to rats being tested on the TUNL task. ChABC infusions into the mPFC initially 
led to a higher percent accuracy, more selection trials completed, and fewer correction trials 
when a novel 20 s delay (condition 4) was introduced in the TUNL task. ChABC infusions into 
the mPFC had no effect on a standard 6 s delay (condition 1), a variable 2 s or 6 s delay 
(condition 2), or an interference condition (condition 3) in TUNL. ChABC infusions into the 
PPC resulted in no effect in any of the 4 TUNL conditions. Notably, immunohistochemistry 
revealed that ChABC infusions into the mPFC increased C4S intensity and decreased WFA 
intensity. Furthermore, ChABC significantly reduced PNN count, PV+ cell count, and the 
percent of PV+ cells surrounded by PNNs. In the PPC, ChABC infusions led to increased C4S 
intensity, but had no effect on WFA intensity, PNN count, PV+ cell count, or the percent of PV+ 
cells surrounded by PNNs.  
 In the present study, stereotaxic coordinates and ChABC volumes for mPFC infusions 
were based on our previous study (Paylor et al. 2018). Like our previous study, mPFC infusions 
of ChABC resulted in significantly increased C4S intensity, indicative of more CSPG stubs, and 
decreased WFA intensity, indicative of fewer intact CSPGs in the ECM. In both the present 
study and our previous study, there was a significant reduction in PNNs following ChABC 
infusions (Paylor et al. 2018). There was also a reduction in PV+ cells in the present study, 
however PV+ cell counts were unaffected in our previous study. PNNs protect the neurons that 
they ensheathe from oxidative stress and support functional cell signaling and ion buffering 
(Morawski et al. 2004; Brückner et al. 1993; Dzyubenko et al. 2016). Consistent with this, PNN 
degradation in the present study may have impaired the physiological function of PV+ 
interneurons that they surrounded, which could have led to PV+ cell loss (Morishita et al. 2015; 
Chu et al. 2018). Alternatively, the experience dependent plasticity of PV+ cell networks could 
explain why there was a PV+ cell reduction in the present study but not our previous study 
(Donato et al. 2013). While the present study tested rats in the TUNL task, our previous study 
tested rats using a battery of tasks including pre-pulse inhibition, set-shifting, reversal learning, 
cross-modal object recognition, and oddity (Paylor et al. 2018). The difference in tasks 
performed between the two studies could have led to differences in PV+ cell networks, which 
	44	
could explain why there was a reduction in PV+ cells in the present study, but not our previous 
study (Donato et al. 2013).  
ChABC infusions into the PPC had no effect on PNN count. The reduction in mPFC 
PNNs but not PPC PNNs in the present study could be the result of larger ChABC spread in the 
PPC, since it has a wider coronal section than the mPFC. A lack of PNN reduction in the PPC 
may also have resulted from infusions being done anterior to the PPC.  Infusions were performed 
between -3.30 and -3.80 mm posterior to bregma, while the PPC was imaged between -3.84 mm 
and -4.68 mm posterior to bregma. Alternatively, it is possible that PNNs in the PPC regrew at a 
faster rate than PNNs in the mPFC. As an example of different brain regions having different 
rates of PNN regrowth, it appears that PNNs in the V1 regrow more quickly than PNNs in the 
mPFC. One group targeted the primary visual cortex (V1) and infused 3.1 µL of ChABC into 
each hemisphere (Lensjø et al. 2016). They found that WFA intensity in the V1 (after being 
normalized to a reference region) went from about 0.05 seven days post surgery to about 0.6 
thirty days post-surgery (Lensjø et al. 2016). In the present study, we injected 0.6 µL of ChABC 
into each mPFC hemisphere, which led to a mPFC normalized WFA intensity of about 0.45 
seven days post surgery to about 0.7 thirty days post surgery. This brain region-dependent PNN 
regrowth rate may explain why PNNs in the mPFC, but not the PPC, were significantly reduced 
in the present study. 
 The battery of TUNL conditions in this study was designed to assess the effects that PNN 
degradation has on spatial WM, susceptibility to interference, and behavioural flexibility. 
Interestingly, in a single 60-minute block of TUNL with a variable 2 s or 6 s delay (condition 2), 
rats performed worst on trials with a 6 s delay and large stimulus separations (Fig. 4A, 8A). 
Conversely, in previous experiments that used constant 2 s and 6 s delays in counterbalanced 30-
minute blocks, rats performed worst on trials with a 6 s delay and small stimulus separations 
(Hurtubise et al. 2017; Davies et al. 2017). This difference implies that rats change their strategy 
in TUNL when tested on a variable versus a constant delay. In general, rats performed better on 
trials with large stimulus separations compared to trials with small stimulus separations. This 
result is consistent with previous studies, and was expected because decreased separation 
distances between stimuli challenge pattern separation more (Davies et al. 2016; Hurtubise et al. 
2017; Scott et al. 2019). Additionally, in general, rats performed better on trials with shorter 
delays compared to trials with longer delays. This too, was expected because increased delays in 
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TUNL challenge WM more. The response latency of rats on incorrect trials was longer than the 
response latency on correct trials, which implies that rats hesitate when unsure of the correct 
choice. 
The results from the present study support the idea that cortical PNNs play a subtle role 
in complex cognitive tasks. Rats treated with mPFC ChABC infusions had initially improved 
percent accuracy, performed more selection trials, and performed fewer correction trials 
compared to controls in the 20 s delay condition. The initial improvement in percent accuracy 
was specific to large stimulus separation trials, and did not occur in small stimulus separation 
trials. This is likely because small stimulus separation trials at a 20 s delay are very challenging, 
and difficult for a rat to perform above chance. The performance of more selection trials can be 
generally attributed to more correct choices being made and lower response latencies. The 
performance of fewer correction trials represents less perseveration on incorrect choices, and can 
be inferred as increased behavioural flexibility (Kumar et al. 2015; Lins et al. 2015; Hurtubise et 
al. 2017). This initial improvement when a 20 s delay was used, but not when 2 s or 6 s delays 
were used, represents a delay-dependent effect, which has previously been observed following 
mPFC manipulation (McAllister et al. 2013; Delatour and Gisquet-Verrier 1999; Herremans et 
al. 1996). Perhaps the improved performance of ChABC-treated rats was related to a period of 
increased synaptic plasticity caused by ChABC, which could have facilitated the functional 
connections of neurons that are involved in WM. Memory improvements coupled with increased 
synaptic plasticity have previously been observed in animals with attenuated PNNs (Carulli et al. 
2010; Morellini et al. 2010; Romberg et al. 2013). Alternatively, the improvement in initial 
performance could be the result of increased behavioural flexibility, because the 20 s delay 
condition was the only condition that introduced a novel delay. Interestingly, one group observed 
a similar effect following mPFC lesions. When they trained rats on a 5 s delay, mPFC lesions 
impaired the performance of rats when tested on a novel 20 s delay (Delatour and Gisquet-
Verrier 1999). However, mPFC-lesioned rats that were trained on a variable 0, 5, 10, or 20 s 
delay were not impaired when switched to a non-variable 20 s delay (Gisquet-Verrier et al. 
2000). The initial improved performance in the 20 s delay condition could also be explained by 
the inability of rats to wait for a stimulus, as this has previously been observed following mPFC 
inactivation (Narayanan et al. 2006). Consistent with this, results indicated a general trend 
towards longer response latencies in ChABC-treated rats compared to controls in all conditions 
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tested. Finally, improved performance following mPFC ChABC, but not PPC ChABC infusions 
was surprising, because WM has been proposed to rely on fronto-parietal circuits (Eriksson et al. 
2015). Perhaps this dissociation is the result of the mPFC and PPC contributing to spatial WM in 
different ways.  
 In conclusion, this experiment showed that modulation of PNNs in the mPFC results in 
subtle consequences for adapting to a novel delay in the TUNL spatial WM task, while PNNs in 
the PPC do not. Automated touchscreen tasks such as TUNL are useful tools because they allow 
for careful control over task difficulty, which can reveal subtle behavioural effects associated 
with PNN reductions. Reduced cortical PNNs have been observed in patients with CNS 
disorders, as well as animal models of CNS disorders. This makes ChABC infusions a valuable 
tool for studying the relationship between PNN reductions and the cognitive deficits seen in CNS 
disorders, because it can acutely degrade PNNs in specific brain areas. However, surgical 
infusions of ChABC are labor intensive and there are issues with these surgeries being done 
repeatedly throughout a rat’s lifespan. Recently, an inducible viral vector has been developed 
that can efficiently and reversibly degrade PNNs by regulated delivery of ChABC (Burnside et 
al. 2018). In future studies, this technology can be used to carefully control PNN density, and can 
be paired with behavioural tasks to study the relationship between PNN density and cognitive 
function. 
 
2.6 Materials and Methods 
2.6.1 Subjects: 
 Forty-eight Long Evans rats were trained on the TUNL task in two separate cohorts. All 
animals were housed in clear, ventilated plastic cages in a temperature-controlled vivarium. Each 
subject was provided with a plastic tube for enrichment, and was maintained on a 12h:12h light-
dark cycle. All experimental procedures were conducted during the light phase, and subjects 
were left undisturbed during the dark phase. Animals were food restricted and were maintained 
at 85% of their free-feeding weight. Water was available ad libitum, except during testing. All 
experiments were approved by the University of Saskatchewan Research Ethics Board and were 
conducted in accordance with the standards of the Canadian Council on Animal Care.  
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2.6.2 Training apparatus:  
 All training and testing took place in eight touchscreen-equipped operant conditioning 
chambers (Lafayette Instruments, Lafayette, IN, USA). These chambers are trapezoidal in shape, 
with a food magazine port positioned parallel and across from the wall with the touchscreen. A 
black polycarbonate mask with 14 squares presented in a 7x2 pattern (7 squares horizontally, 2 
squares vertically) covered the touchscreen during the TUNL task. This pattern was visually 
obstructed with the use of a spring-loaded “response shelf” that rats needed to intentionally press 
down in order to nose-poke the touchscreen. On the opposite side of the chamber, the food 
magazine dispensed odorless reward pellets (Dustless Precision Pellets, 45 mg, Rodent Purified 
Diet; BioServ, Frenchtown, NJ). This food magazine was also equipped with a reward light and 
an infra-red nose-poke detector. A metal mesh with holes constituted the floor of the chamber, 
and the roof was a transparent plastic lid. Each operant conditioning chamber was located on a 
sliding shelf at the base of a sound-attenuating large wooden box. In addition to the chamber, 
each box contained a pellet dispenser, video camera, small ventilation fan, and a house light that 
was activated following incorrect responses. 
 
2.6.3 Handling and habituation: 
 Upon being transported to the vivarium, rats were left undisturbed for a minimum of two 
weeks. After this time, they were each handled for two consecutive days prior to when training 
began. Each rat was handled in the touchscreen rooms to familiarize them to that environment. 
To get to this room from the vivarium, rats were transported up an elevator with the use of a cart. 
After becoming accustomed to this transportation route and handling for three days, rats were 
habituated to the touchscreen box. On the first day of habituation, each rat was assigned to and 
placed into a specific touchscreen chamber for one hour. During this time, ten reward pellets 
were manually placed into the touchscreen’s magazine port, and all technology was turned on (2 
computers, each controlling 4 touchscreen devices).  
 
2.6.4 TUNL pretraining: 
 The pretraining protocol followed a modified version of the instructions provided by 
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Lafeyette, which involved completion of a series of stages until criterion was reached. TUNL 
pretraining was composed of four stages: initial touch, must touch, must initiate, and punish 
incorrect. Initial Touch Training introduced the rats to the touchscreen stimuli and their 
relationship to a food reward. During each trial, 1 of the 14 squares was illuminated. When a rat 
touched the illuminated square, 3 reward pellets were immediately dispensed into the food port. 
If the illuminated square was left untouched for 30 seconds, however, the stimulus was removed 
and only a single pellet was dispensed. Each trial was followed by an ITI period of 20 seconds.  
In order to reach criterion for Initial Touch Training, rats must have completed 100 trials in 60 
minutes. During each trial of Must Touch Training 1 of the 14 squares were illuminated, but they 
remained lit until touched by a rat, upon which time a single reward pellet was dispensed. 
Criterion for this stage involved completing 100 trials in 60 minutes. During Must Initiate 
Training, rats are required to poke their nose in the food magazine to initiate trials identical to 
those in Must Touch Training. Criterion involved completing 100 trials in 60 minutes. The final 
pretraining stage was Punish Incorrect Training, in which each trail began with a rat poking its 
nose into the food reward port. This led to the presentation of a stimulus (illuminated square). If 
a rat touched the stimulus, a reward pellet was dispensed and a new trail began following an ITI. 
If the rat touched an unilluminated square, however, a timeout period began. During the timeout, 
no reward pellet was dispensed, the house light turned on for 5 seconds, and then an ITI began. 
The previous trial was then repeated until the rat correctly selected the correct stimulus (these 
repeated trials were termed as ‘correction trials’). Criterion was the completion of 100 trials 
within 60 minutes with >80% accuracy on two consecutive days. 
2.6.5 TUNL task acquisition: 
 After a rat completed pretraining, it was moved on to learn the standard TUNL task (Fig. 
2). Each trial began by a rat poking its nose into the reward magazine. This initiated the sample 
phase, in which 1 of the 14 squares was lit. If a rat touched one of these illuminated squares, 
there was a 1 in 3 chance of a pellet being dispensed, and the stimulus was removed from the 
screen for a 2 second delay. Following the delay, the rat was required to poke its nose into the 
reward magazine to start the choice phase. During this phase, the sample square and a novel 
square were illuminated simultaneously. A correct response was made when the rat touched the 
novel square (non-matched to the sample square). Correct responses led to a reward pellet being 
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dispensed, followed by a 20 second ITI. A new ‘selection trial’ began at the end of the ITI, with 
a new square being illuminated that had to be different from the previous trial’s stimulus. If an 
incorrect response was made, with the rat selecting the sample square, the house light turned on 
for 5 seconds and no reward was dispensed. After this timeout period, a 20 second ITI would 
begin, followed by a trial identical to the previous trial. Trials that repeat the same illuminated 
sample and choice square stimuli are termed ‘correction trials’, and are repeated consecutively 
until a correct choice is made. Accuracy was recorded automatically as a measure of the percent 
of correct responses made during correction trials. During this TUNL acquisition phase, rats 
were required to complete 42 trials in 30 minutes. Once the majority (>50%) of rats reached this 
criterion, all rats were simultaneously moved onto the final 6-second delay TUNL task (from the 
2s TUNL acquisition task). In this final TUNL task, rats were trained until they completed a 
minimum group average of 50 trials at 65% accuracy.  
2.6.6 mPFC infusions of PEN or ChABC: 
 Twenty-four rats were assigned to the mPFC condition, with twelve receiving PEN 
treatment and twelve receiving ChABC treatment. Before the operation, injectors were made 
from 35Ga silica tubing (WPI, Sarasota, FL), glued to PE-50 tubing, and then set up with the 
stereotaxic apparatus. Prior to and throughout the procedure, rats were anesthetized with an 
isoflurane gas inhalant (Janssen, Toronto, ON). All rats were administered a 0.5mg/kg 
subcutaneous dose of the analgesic Anafen (Merial Canada Inc, QC) prior to surgery. Once 
anesthetized, animals were positioned in the stereotaxic apparatus. Next, the scalp was cut with a 
scalpel and retracted to expose the skull. Holes were then drilled into the skull and the injectors 
set up with stereotaxic apparatus were inserted bilaterally at the following coordinates: 
anteroposterior (AP) +3.0 mm; lateral (L) 0.7 mm; dorsoventral (DV) 4.4 mm relative to bregma. 
From there, either ChABC (100 units/mL) or PEN (100 units/mL) (depending on the treatment 
group) was infused at the DV coordinates -4.4 mm, -4.2 mm, and -3.9 mm. These infusions were 
performed at a rate of 0.3 µL per minute for 2 minutes (total infusion volume of 0.6 µL/side). 
Injectors were left in place for an additional 6 minutes to allow for diffusion of the solution away 
from the final infusion site (DV= -3.9mm). After this time the injectors were slowly removed, 
the holes in the skull were filled with bone wax, and then the wound was closed with stitches.  
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2.6.7 PPC infusions of PEN or ChABC: 
 Twenty-four rats were assigned to the PPC condition, with twelve receiving PEN 
treatment and twelve receiving ChABC treatment. Surgery set-up and anesthetization of animals 
matched that of mPFC infusions. Once anesthetized, animals were positioned in the stereotaxic 
apparatus. Next, the scalp was cut with a scalpel and retracted to expose the skull. Holes were 
then drilled into the skull and the injectors set up with stereotaxic apparatus were inserted 
bilaterally at and anterior location and a posterior location. The anterior location had the 
following coordinates: AP -3.30 mm; L 2.80 mm; DV -1.20 mm relative to bregma. The 
posterior location had the following coordinates: AP -3.80 mm; L 3.00 mm; DV -1.30 mm 
relative to bregma. From there, either ChABC (100 units/mL) or PEN (100 units/mL) (depending 
on the treatment group) was infused at the anterior location with the DV coordinates of -1.10 mm 
and -1.00 mm, and at the posterior location with the DV coordinates of -1.30 mm and -1.20 mm. 
These infusions were performed at a rate of 0.3 µL (anterior) or 0.6 µL (posterior) per minute for 
2 minutes (total infusion volume of 0.6 µL/side at the anterior location and 1.2 µL/side at the 
posterior location). Injectors were left in place for an additional 6 minutes to allow for diffusion 
of the solution away from the final infusion site (anterior DV= -1.0 mm, posterior DV= -1.20 
mm). After this time the injectors were slowly removed, the holes in the skull were filled with 
bone wax, and then the wound was closed with stitches.  
2.6.8 TUNL testing protocol: 
 Testing was performed between 5 to 10 days after surgery. The first 3 days (testing days 
1-3) of testing consisted of a standard 6 s delay TUNL task. This tested the effect of ChABC on 
the same condition that rats were trained on. The next 4 days of testing (testing days 4-7) 
consisted of a variable 2 s or 6 s delay to test delay-dependent changes in WM. The following 2 
days (days 8-9) tested for interference, in which the delay was set to 2 s and the ITI period was 
set from 20 s to 1 s. Finally, the final 6 days of testing (testing days 10-15) consisted of a 
challenging and novel 20 s delay period. The amount of testing days in each condition was based 
on the average number of selection trials performed per day within that condition. Each testing 
condition consisted of a total of 150-300 selection trials. One rat from the mPFC ChABC group 
was excluded as an outlier in each of the 4 conditions, as the number of selection trials that they 
completed in each condition was greater than 2 standard deviations from the mean.  
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2.6.9 Tissue collection: 
 After behavioural testing, rats were deeply anesthetized with isofluorane. Once fully 
anesthetized, they were perfused with PBS followed by 4% paraformaldehyde using infusion 
pumps. Following perfusion, brains were extracted and stored in a sucrose azide solution (30% 
sucrose, 0.1% azide in a water solvent) at 20°C. Next, the brains were mounted onto a chuck 
with optimal cutting temperature (OCT) gel and frozen using cold, pressurized carbon dioxide 
gas. They were then sectioned using a sliding microtome at 40µm and collected in a bath of 
0.05M PBS. 
2.6.10 Immunohistochemistry:  
 Slices were stored on slides in a -20-degree freezer until they were removed and thawed 
to room temperature (20 mins) prior to the immunohistochemistry protocol. Slides were washed 
3 times in 1X PBS for 10 mins each. After this, slides were incubated with 10% Protein Block, 
serum-free (Dako) in 1X PBS for 1 hour. Slides were then incubated overnight with a primary 
antibody solution of 1% Protein Block, 1% Bovine Serum Albumin, and 98% 1X PBS with 0.1% 
Triton X-100 detergent. Primary antibodies used were as follows: mouse anti-chondroitin-4-
sulfate (C4S; 1:400; Millipore), Wisteria Floribunda Agglutinin (WFA; 1:1000; Swant), rabbit 
anti-Parvalbumin (PV; 1:1000; Swant). The following day, slides were again washed 3 times, 
twice in PBS 1X with 1% Tween-20 and then once in PBS 1X. Slides were then incubated for 1 
hour with secondary antibodies as follows: donkey anti-mouse Alexa Fluor 488 (1:200; 
Invitrogen), donkey anti-rabbit Alexa Fluor 546 (1:200; Invitrogen), and Streptavidin 647 
(1:200; Invitrogen). After the 1-hour secondary incubation, slides were washed three times, twice 
in PBS 1X with 1% Tween-20 and once with PBS 1X. Slides were then labelled with 4’,6-
diamidino-2-phenylindole (DAPI) in Vectashield mounting medium (Vector Labs) and a cover 
slip was placed over the slide.  
 
2.6.11 Widefield Epifluorescence Microscopy: 
 Images of sections were acquired on a LEICA DMI6000B Microscope using LAS AF 
computer software. To landmark the mPFC and PPC we used The Rat Brain in Stereotaxic 
Coordinates and selected based on features identified in the DAPI nuclear staining pattern 
(Paxinos & Watson 2007). The mPFC was imaged between +2.76 mm and +3.24 mm anterior to 
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bregma with the imaging window extending from the midline through cortical layers 1-6. All 
images for analysis were captured at 10X magnification and 6 images were taken per animal. 
Images from the somatosensory cortex were taken from within the same sections as images for 
the mPFC (+2.76 mm to +3.24 mm), to control for any variability between animals in staining 
intensity. The PPC was imaged between -3.84 mm and -4.68 mm posterior to bregma with the 
imaging window extending from the dorsal surface of the brain through cortical layers 1-6. 
Within the LAS AF software, a constant gain, exposure, and light intensity was used across all 
animals. 
2.6.12 Image Analysis: 
 Tissue analysis was conducted on unmodified images by an experimenter blind to the 
experimental conditions. Staining intensity was quantified from all stains using the automated 
quantification software CellProfiler (Lamprecht et al. 2007) Images were loaded into the 
software and analyzed using the MeasureImageIntensity module. Cell numbers were counted 
manually using the ImageJ Cell Counter function. 
 
2.6.13 Statistical Analyses: 
 All data are presented as mean ± SEM. Statistical analyses were conducted in SPSS (IBM 
SPSS Statistics 25) using two-tailed independent-samples t-tests and mixed ANOVAs with 
repeated measures. Significance was set at p < 0.05.  
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3.0 GENERAL DISCUSSION 
 In the following section, I will discuss outstanding issues and details that were not 
included in the manuscript. Notably, I will also assess how the TUNL task measures the WM of 
rodents, and whether TUNL for rodents is relatable to human measures of WM. Additionally, 
based on the results from the current study, I will propose ideas and directions for future 
research. 
3.1 The Performance of Rats in TUNL With a Constant Versus Variable Delay   
 An interesting result was observed in TUNL with a variable 2 s or 6 s delay (condition 2) 
when either the mPFC or the PPC was targeted. In this condition, both PEN and ChABC-treated 
rats performed best on trials with a 2 s delay and large stimulus separations and worst on trials 
with a 6 s delay and large stimulus separations (Fig. 4A, 8A). Conversely, in previous 
experiments that used constant 2 s and 6 s delays in counterbalanced 30-minute blocks, rats 
performed best on trials with a 2 s delay and large stimulus separations, but worst on trials with a 
6 s delay and small stimulus separations (Hurtubise et al. 2017; Davies et al. 2017). In theory, 
trials with a 6 s delay and small stimulus separations are the most difficult because they 
challenge both spatial WM and spatial pattern separation the most. Therefore, it is logical that 
when rats performed TUNL with constant 2 s and 6 s delays in counterbalanced 30-minute 
blocks, they performed best on these types of trials. Perhaps that when tested on a variable 2 s or 
6 s delay, rats expected a shorter 2 s delay during 6 s delay trials, which could have led them to 
approach the response shelf prematurely. If they habitually approached the same area of the 
response shelf where the stimulus was presented in the sample phase of TUNL, this would make 
them more likely to choose the incorrect choice on 6 s delay trials with large stimulus 
separations.  
 
3.2 PV+ Cell Loss Following ChABC Infusions into the mPFC 
 There was a reduction in PV+ cells in the present study, however PV+ cell counts were 
unaffected in a previous study from our lab (Paylor et al. 2018). It is possible that PNN 
degradation in the present study may have impaired the physiological function of PV+ 
interneurons that they surrounded, which could have led to PV+ cell loss (Morishita et al. 2015; 
Chu et al. 2018). PNNs provide a negatively charged polyanionic microenvironment around the 
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neurons that they surround, which can aid in ion buffering (Brückner et al. 1993). Additionally, 
there is evidence that PNNs protect the neurons that they ensheathe from oxidative stress 
(Morawski et al. 2004). For example, an inverse relationship has been discovered between the 
degree of oxidative stress displayed within PV+ neurons and the robustness of the PNN that 
surrounds them (Cabungcal et al. 2013). Additionally, key link proteins in PNNs such as 
aggrecan and tenascin-R help to protect neurons from iron-induced oxidative stress and 
neurodegeneration (Suttkus et al. 2014). It is possible that PNN degradation led to an 
accumulation of reactive oxygen species in PV+ neurons, which in turn could have led to either 
unregulated or apoptotic cell death (Morawski et al. 2004; Suttkus et al. 2014; Cabungcal et al. 
2013).  
 Perhaps there is a temporal delay between PNN degradation and PV+ cell loss, which is 
an alternative explanation to the significant reduction of PV+ cells in the present study, but not in 
the previous study from our lab (Paylor et al 2018). Rats in the present study were sacrificed 
approximately 30 days after ChABC infusions, whereas in our lab’s previous study they were 
sacrificed approximately 20 days after ChABC infusions (Paylor et al. 2018). PV+ cell loss may 
have occurred between 20-30 days post surgery. Alternatively, the experience dependent 
plasticity of PV+ cell networks could explain why there was a PV+ cell reduction in the present 
study but not the previous study (Paylor et al 2018). While rats were tested in the TUNL task in 
the present study, rats were tested using a battery of tasks including pre-pulse inhibition, set-
shifting, reversal learning, cross-modal object recognition, and oddity in the previous study 
(Paylor et al. 2018). The difference in tasks performed between the two studies could have led to 
differences in PV+ cell networks, and theoretically could explain the discrepancy of PV+ cell 
loss between the two studies (Donato et al. 2013). 
 
3.3 Interpretation of the Improved Performance in TUNL with a 20 s delay Following ChABC 
Infusions into the mPFC 
There are many reasons that could explain the improved initial performance of mPFC 
ChABC-treated rats in the 20 s delay condition. For example, perhaps this improvement was 
related a period of increased synaptic plasticity caused by ChABC, which may have facilitated 
the functional connections of neurons that are involved in spatial WM. Memory improvements 
coupled with increased synaptic plasticity have previously been observed in animals with 
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attenuated PNNs (Carulli et al. 2010; Morellini et al. 2010; Romberg et al. 2013). For example, 
long-term potentiation of excitatory synapses on pyramidal neurons has been observed following 
PNN degradation (Carstens et al. 2016).  
Alternatively, the improvement in initial performance following ChABC into the mPFC 
could be the result of increased behavioural flexibility, because the 20 s delay condition was the 
only condition that introduced a novel delay. Every other condition used a 2 or 6 s delay period, 
which rats were habituated to during training. ChABC-treated rats also performed fewer 
correction trials than controls, which is indicative of increased behavioural flexibility (Scott et al. 
2019; Kumar et al. 2015). In support of this theory, one group degraded PNNs in the cortex with 
hyaluronidase, which resulted in enhanced flexibility in reversal learning (Happel et al. 2014).  
The initial improved performance in the 20 s delay condition following ChABC infusions 
into the mPFC could also be explained by the inability of rats to wait for a stimulus, as this has 
previously been observed following mPFC inactivation (Narayanan et al. 2006). The mPFC of 
rats were reversibly inactivated by muscimol, which caused a higher percentage of premature 
responses on trials relative to controls. Interestingly, during the recovery period following the 
reversible inactivations, rats no longer had a higher percentage of premature responses. In the 
present study, the response latencies in ChABC-treated rats were generally longer compared to 
controls in all mPFC TUNL conditions tested. Perhaps ChABC infusions reduced rushed 
responding in the 20 s delay condition of the TUNL task, which could have led to the 
improvement in percent accuracy, selection trials, and correction trials seen in the present study. 
 
3.4 Why Do PNNs in the mPFC, and not the PPC Appear to Play a Role in TUNL? 
Improved performance following mPFC ChABC, but not PPC ChABC infusions was 
surprising, because WM has been proposed to rely on fronto-parietal circuits (Eriksson et al. 
2015). With that being said, multiple tracts relay information between these brain regions. 
Perhaps the dissociation in TUNL performance following either mPFC or PPC PNN degradation 
was due to PNNs in these areas being differentially involved in spatial WM. In support of this, 
one group found that lesions to the mPFC, but not the PPC, impaired the performance of rats in a 
nonmatching to position task that tests spatial WM (Kolb et al. 1994). Alternatively, perhaps the 
dissociation in TUNL performance between PNN degradation in the mPFC and PPC was due to 
differing distributions of PNNs in these regions. PNNs in different brain regions preferentially 
	56	
ensheathe specific subtypes of neurons. For example, PNNs in the mPFC mainly ensheathe PV+ 
GABAergic interneurons, whereas the CA2 region of the hippocampus has a dense expression of 
PNNs around excitatory pyramidal neurons (Carstens et al. 2016; Paylor et al 2018). Based on 
data from the current study, it appears that that PNNs in the PPC associate more commonly with 
PV+ cells than PNNs in the mPFC (Fig. 12G, 14G). There is evidence that the degradation of 
PNNs surrounding PV+ inhibitory neurons leads to increased excitability among fast spiking 
neurons coupled with increased synaptic plasticity (Balmer 2016; Pizzorusso et al. 2002). 
Conversely, the degradation of PNNs surrounding excitatory pyramidal neurons appears to 
suppress the plasticity of excitatory synapses (Carstens et al. 2016). Therefore, the differing 
distribution of PNNs among different cell subtypes in the mPFC compared to the PPC could 
result in differences in plasticity following PNN degradation in the two brain regions. In theory, 
this difference could have influenced the effect that PNN degradation in the mPFC versus the 
PPC had on TUNL performance. 
 
3.5 The Relation of the Rodent TUNL task to Human Working Memory 
TUNL has many advantages over other tasks that measure spatial WM in rats, however 
the validity of TUNL as a model of human spatial WM can be called into question. In human and 
primate studies, a heavy emphasis has been placed on visual and spatial tasks when assessing 
WM (Brigadoi et al. 2017; Courtney et al. 1998; Hecker and Mapperson 1997). This is logical, 
because humans and primates rely heavily on visual information to navigate their environment. 
For a long time, it has been questioned whether primates and rodents have similar evolutionary 
neural backgrounds with regards to WM (Tsutsui et al. 2016). Rats and humans navigate and 
interact with their environments in different ways, and it is possible that rats rely more on 
olfactory and tactile WM than visual WM. As such, direct comparisons between rat and human 
spatial WM may not be the most translational approach. Additionally, the ecological validity of 
the TUNL task can be called into question. Rats in TUNL are placed in a small box in which 
there are few novel olfactory or tactile cues between sessions. In the wild, however, the visual 
WM of rats would be combined with cues from other sensory modalities. Therefore, perhaps a 
multisensory WM task is the most appropriate way to measure WM in rats. The human 
CANTAB test for spatial WM that TUNL is based on presents similar problems to TUNL. It is 
not necessarily appropriate to study human spatial WM in isolation, because many socioaffective 
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factors such as stress can affect WM in real-life scenarios (Luethi et al. 2008; Curci et al. 2013).  
With all of this being considered, TUNL still has many translational advantages in the 
study of WM. It is an automated test that has high face validity in the sense that the TUNL task 
very much resembles the CANTAB spatial WM test in humans (Bussey et al. 2012). 
Additionally, when compared to other non-matching tasks such as the DNMP task, it has large 
advantages. The TUNL task causes relatively low levels of stress to rats prior to testing because 
it requires little handling of animals due to its automation (Bussey et al. 2012). Additionally, its 
automated capabilities allow it to record large amounts of information such as response latencies, 
blank touches, and information regarding stimulus separations in an efficient manner (Talpos et 
al. 2012). To conclude, a visual WM paradigm may not be the most effective way of assessing 
WM in rodents, and there is value in developing a multisensory measure of WM. With that being 
said, TUNL has high face validity and currently appears to be the best translational task for 
testing spatial WM in rodents. 
 
3.6 Future Directions 
The lack of reductions in WFA intensity (Fig. 13D) and PPC PNN counts (Fig. 14E) 
between PEN and ChABC-treated rats makes the behavioural results following PPC 
manipulation difficult to interpret. In future studies, it would be valuable to assess WFA intensity 
in the PPC within 7 days of surgery, as was done for the mPFC (Fig. 15). This would give an 
idea of whether initial infusions of ChABC were successful in the PPC, and could reveal the rate 
at which PNNs regrow in the PPC over time. In future studies, it would also be interesting to pair 
ChABC infusions with MMP inhibitors in the mPFC to see if the ChABC-driven improvement 
in the 20 s TUNL condition can be reduced or inhibited altogether. Additionally, it would be 
valuable to assess how synaptic plasticity was affected following mPFC and PPC ChABC 
infusions. In a previous study from our lab, we used a gephyrin+ puncta stain and did not detect 
any significant changes in presynaptic terminals on inhibitory synapses following mPFC ChABC 
infusions (Paylor et al. 2018). In future studies, we could also use a gephyrin+ puncta stain in the 
PPC following ChABC infusions to determine whether synaptic plasticity was affected. 
Additionally, using whole-cell recordings to assess cell excitability following ChABC infusions 
into the mPFC and the PPC could be valuable in assessing the effect of ChABC on local 
excitatory-inhibitory balance. In future studies, it would also be valuable to study the effect that 
	58	
ChABC infusions into the hippocampus have on TUNL, because like the mPFC and the PPC, the 
hippocampus contains PNNs and plays an important role in spatial WM. 
A limitation of TUNL in the current study is that it assesses both attention and spatial 
WM, which are two processes that are not easily dissociated (Awh and Jonides 2001; Awh et al. 
2006). In a future experiment, rats could be tested on the automated 5-Choice Serial Reaction 
Time Task following mPFC ChABC infusions, because it is a task that tests attention without 
any involvement of spatial WM (Turner et al. 2015). Based on the results of such a test, it could 
be concluded whether spatial WM or attention mediated the improvement in the 20 s delay 
TUNL task. Additionally, it would also be interesting to study the effect of mPFC ChABC 
infusions on a rule-switching task that measures behavioural flexibility. In the current study, rats 
were trained extensively in the TUNL task prior to ChABC infusions. In future studies, infusions 
of ChABC into the mPFC and the PPC can be done prior to rats being introduced to TUNL. 
PNNs play important roles in learning, and it is would be interesting to test whether PNN 
degradation affects the rate at which rats can acquire TUNL. 
 ChABC infusions are an effective tool for degrading PNNs and studying the behavioural 
outcomes associated with such degradation. Unfortunately, however, surgical infusions of 
ChABC are labor intensive and there are issues with surgeries being done repeatedly throughout 
a rat’s lifespan. Recently, an inducible viral vector has been developed in mice that can 
efficiently and reversibly degrade PNNs by regulated delivery of ChABC (Burnside et al. 2018). 
In future studies, this technology could be used to carefully control PNN density throughout 
postnatal development, and can be paired with TUNL to study the relationship between PNN 
density and spatial WM over a rodent’s lifetime. With that being said, brevican knockout mice 
that are deficient in PNNs do not show any changes in learning and memory (Brakebusch et al. 
2002). Additionally, the use of this inducible vector lacks brain region specificity with regards to 
PNN degradation, and therefore depending on the research question, may not be the most 
effective tool in follow-up studies.  
 In conclusion, the results gathered from the current study suggest that PNNs in the mPFC 
play a subtle role in adapting to a novel delay in a spatial WM task. Additionally, it appears that 
PNNs in the PPC are not involved in TUNL, however this claim cannot be made with complete 
confidence because PNN degradation in the PPC was not confirmed 30 days post surgery. Future 
	59	
experiments should help to confirm the findings of the present study, as well as test the role that 
PNNs in other brain regions have on learning and memory. 
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